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Abstract
The term “dioxins” generally means a heterogenous mixture of chlorinated dibenzo-p-dioxins and
dibenzofurans (PCDD/Fs). Dioxins are widespread and persistent environmental contaminants, and
due to their lipophilicity and slow metabolism they accumulate in food chain. 2,3,7,8-
Tetrachlorodibenzo-p-dioxin (TCDD) is the most toxic dioxin congener, and is referred to as ”the
most toxic man-made compound”.
Humans are exposed to dioxins primarily via the food. In Finland, 80% of human exposure comes
from fish, Baltic fish being the most crucial source. Therefore, the European Commission is
planning actions to limit the consumption of Baltic fish, especially herring and salmon.
TCDD causes a wide variety of biochemical and toxic effects that are mostly mediated through the
aryl hydrocarbon receptor (AHR). These effects have been reported in multiple species and at
different stages of development. Defects in the developing male reproductive system and teeth are
among the most sensitive endpoints of TCDD toxicity in laboratory animals.
This study outlines two important questions in dioxin risk assessment:
(1) What is the role of genetic factors in sensitivity to dioxins?
This issue was examined using two different animal models: a mouse model with Ahr null mutation
and a rat model based on exceptional resistance to TCDD acute lethality. The TCDD resistance of
these rats is due to a mutated Ahr allele (Ahrhw) and an unknown allele Bhw.
Although the resistance alleles increase the resistance to hexachlorodibenzo-p-dioxin (HxCDD) -
induced acute lethality remarkably less than to TCDD and results in exceptional relative sensitivity
to HxCDD, the study showed that the rats with Ahrhw and/or Bhw resistance alleles are not
exceptionally sensitive to HxCDD–induced non-lethal short-term effects.
An efficacy (magnitude of effect) ratio of 0.5 between resistant and sensitive rats was found to
categorize the dioxin short-term toxicity into different type I and type II endpoints. The resistance
alleles do not modify type I endpoints (CYP1A1 induction, thymic atrophy and tooth defects), while
especially the Ahrhw reduce the efficacy of type II endpoints (decreased body weight and liver
toxicity).
Although most if not all effects of TCDD on the developing prostate in mice were shown to be
AHR mediated, the mutated Ahrhw in rats was still able to normally mediate the TCDD-induced
defects in male reproductive organ development after adult and perinatal TCDD exposure.
However, the extent of the decrease in sperm numbers after perinatal TCDD exposure was reduced
by the resistance alleles.
(2) How is dioxin sensitivity altered at different developmental stages?
Toxic effects of TCDD on male reproductive system were observed in fetuses exposed to at least
100-times lower doses compared to those that alter male reproductive system after adult exposure.
The critical time window for TCDD defects in developing prostate was found to differ among
different prostate lobes. The growth of ventral and anterior prostate was most affected during fetal
period, while that of dorsolateral prostate required both fetal and postnatal exposure for maximal
effect.
The development of resistance to acute lethality differed between rats having either one of the
resistance alleles. Rats with Ahrhw were resistant to TCDD when assessed a few days after birth,
while rats with allele Bhw did not attain their resistance until four to six weeks after birth. This
reflects basic differences in pathways mediating resistance linked to these alleles.
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Tiivistelmä (Abstract in Finnish)
Dioksiineilla tarkoitetaan yleensä epäyhtenäistä kemikaalien ryhmää, johon kuuluvat mm. klooratut
dibentso-p-dioksiinit ja dibentsofuraanit (PCDD/F). Dioksiinit ovat laajalle levinneitä ja kestäviä
ympäristösaasteita, jotka kertyvät ravintoketjussa. 2,3,7,8-Tetraklooridibentso-p-dioksiini (TCDD)
on myrkyllisin dioksiinijohdos ja sitä pidetään yhtenä myrkyllisimmistä ihmisen syntetisoimista
yhdisteistä.
Ihmiset altistuvat dioksiineille pääasiassa ravinnon kautta. Jopa 80% suomalaisten altistuksesta on
peräisin kalasta, erityisesti Itämeren rasvaisista kaloista kuten silakasta ja lohesta. Euroopan
komissio on rajoittanut Itämeren kalan käyttöä.
TCDD vaikuttaa AH-reseptorin kautta ja aiheuttaa monia biokemiallisia ja toksisia vaikutuksia,
joita on havaittu eri eläinlajeilla ja eri kehitysvaiheissa. Vaikutukset hampaiden ja urosten
lisääntymiselimistön kehitykseen ovat herkimpiä TCDD:n vaikutuksia koe-eläimillä.
Tässä väitöskirjassa selvitettiin kahta dioksiinien riskinarvioinnin kannalta keskeistä kysymystä:
(1) Kuinka geneettiset tekijät vaikuttavat dioksiiniherkkyyteen?
Työssä käytettiin eläinmalleja, jotka perustuivat toiminnallisen AH-reseptorin puuttumiseen
(hiirimalli) sekä mutatoituneesta AH-reseptorialleelista (Ahrhw) ja toistaiseksi tuntemattomasta
alleelista Bhw johtuvaan poikkeuksellisen suureen TCDD:n sietokykyyn (rottamallit).
Vaikka rotat, joilla on Ahrhw ja Bhw resistenssialleelit, ovat suhteellisesti herkempiä
heksaklooridibentso-p-dioksiinin (HxCDD) aiheuttamalle kuolleisuudelle kuin TCDD:n
aiheuttamalle kuolleisuudelle, eivät nämä rotat ole kuitenkaan poikkeuksellisen herkkiä HxCDD:n
aiheuttamille biokemiallisille ja muille tyypillisille toksisuuden ilmenemismuodoille, kuten
ruumiinpainon laskulle.
Kestävien ja herkkien rottien annos-vasteen analysoiminen osoitti, että lyhytaikaisen
dioksiinialtistuksen aiheuttamat toksiset vasteet voidaan jakaa kahteen ryhmään, tyypin I ja tyypin
II vasteisiin. Luotettavimmaksi luokittelukriteeriksi osoittautui vasteen teho (maksimivasteen
suuruus). Tyyppi I:n vasteissa tehon suhdeluku kestävän ja herkän rottakannan välillä on 	
kestävän kannan maksimivaste on yli puolet herkän kannan maksimivasteesta). Tällaisia vasteita
ovat mm. CYP1A1 induktio, kateenkorvan pieneneminen ja hammasvauriot, ja resistenssialleelit
eivät siis vaikuta niihin.Tyyppi II:n vasteissa dioksiinien teho pienenee erityisesti Ahrhw alleelin
vaikutuksesta ja tehon suhdeluku on <0.5 (eli kestävän kannan maksimivaste on alle puolet herkän
kannan maksimivasteesta). Tyyppi II:n vasteita ovat mm. ruuminpainon lasku ja maksavaurio.
Vaikka suurin osa TCDD:n vaikutuksista kehittyvän hiiren eturauhaseen oli AH-reseptorivälitteisiä,
ei mutatoitunut Ahrhw muuttanut TCDD:n vaikutusta urosten lisääntymiselimiin rotilla. Sitävastoin
TCDD-altistuksen aiheuttama siittiöiden määrän lasku oli suurin rotilla joilla ei ole kumpaakaan
resistenssialleeleista.
(2) Miten dioksiiniherkkyys riippuu kehitysvaiheesta?
Kehittyvä urosrottien lisääntymiselimistö oli sikiöaikana ja imetyksen aikana jopa 100-kertaa
herkempi kuin aikuisten rottien lisääntymiselimistö. Eturauhasen eri lohkot eivät ole saman
aikaisesti herkkiä TCDD:n toksisille vaikutuksille. Ventraalinen ja anteriorinen lohko ovat herkkiä
sikiöaikaiselle altistukselle. Sen sijaan dorsolateraalisen eturauhasen kehityshäiriöitä todettiin vain
sekä sikiöaikaisen että syntymänjälkeinen TCDD altistuksen jälkeen.
Resistenssialleeleihin Ahrhw ja Bhw liittyvä kestävyyden kehittymisaikataulu TCDD:n aiheuttaman
akuutin kuolleisuuden suhteen oli selvästi erilainen. Rotat joilla oli Ahrhw resistenssialleeli olivat
kestäviä jo muutama päivä syntymän jälkeen, kun taas rotilla joilla oli Bhw alleeli kestävyys ilmeni
vasta 4-6 viikon ikäisenä. Tämä viittaa eroihin alleeleihin liittyvissä kestävyyden mekanismeissa.
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List of abbreviations
AH  Aryl hydrocarbon
AHR Aryl hydrocarbon receptor, Ah receptor, dioxin receptor
Ahr the gene encoding AHR
Ahr-/- Aryl hydrocarbon knock-out (AHRKO); both alleles of Ahr are inactivated
using gene targeting technology
Ahrb Allele of Ahr locus; high affinity; found in TCDD-responsive C57BL/6J
mice
Ahrd Allele of Ahr locus; low affinity; found in TCDD-non-responsive DBA/2J
mice
Ahrhw Allele of Ahr locus; found in exceptionally TCDD-resistant Han-Wistar rats.
Ahrwt Allele of Ahr locus; found in most rats strains, e.g. Long-Evans and Sprague
Dawley rats.
AHRKO Aryl hydrocarbon receptor knock-out; both alleles of Ahr are inactivated
using gene targeting technology (Ahr-/-)
AHRR Aryl hydrocarbon receptor repressor; inhibits AHR function by competing
with AHR for dimerizing with ARNT and thereby inhibits binding to the
DRE sequence
ARNT Ah receptor nuclear translocator: dimerizes with AHR and this heterodimer
binds to DNA
ASAT Aspartate aminotransferase: enzyme released into the blood when certain
organs or tissues, particularly the liver and heart, are injured
B an unknown gene that affects TCDD-sensitivity; Bhw allele increases
resistance indicated by some end points
bHLH/PAS Basic helix-loop-helix/PAS: AHR belongs to this family of transcriptional
regulators
C57BL/6J Mouse strain; sensitive to the effects of aryl hydrocarbons
cDNA Complementary DNA, reverse-transcribed from mRNA
c-src A gene encoding a 60 kDa protein p60c-src possessing tyrosine kinase activity
CYP Cytochrome P450: xenobiotic, oxidizing enzymes forming a CYP
superfamily
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DBA/2J Mouse strain; resistant to the effects of aryl hydrocarbons
DHT 5α-Dihydrotestosterone; an androgen that is produced from testosterone by
5α-reductase activity. Stimulates the growth of prostate gland
3α-Diol 5α-Androstane-3α,17ß-diol, predominant androgen prior to puberty
DNA Deoxyribonucleic acid: a double-stranded nucleic acid that contains the
genetic information of organisms
DRE Dioxin responsive element: a specific sequence of DNA that binds the AHR-
ARNT complex
ED50 Effective dose 50%: the dose that is estimated to give 50 % of the maximal
response
ECEH-WHO European Center of Environmental Health of the World Health Organization
EC SCF European Commission Scientific Committee on Foods
EROD Ethoxyresorufin-O-deethylase; EROD activity is almost exclusively due to
the enzyme CYP1A
FFA Free fatty acid; non-esterified fatty acids
GD Gestation day; days from conception until birth
HIF-1α Hypoxia inducible factor 1α; member of bHLH/PAS family of
transcriptional regulators
HxCDD 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin
HpCDD 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin
H/W Han/Wistar (Kuopio) rat strain; the most TCDD-resistant laboratory animal
known
ICZ Condensation product formed in stomach from dietary indole, indole-3-
carbinol naturally occurring in i.e. cabbage. ICZ has high affinity to AHR
and is a potent inducer of AHR-dependent gene expression in vitro.
KY-5 Commercial name for chlorophenol mixture used in Finland as a wood
preservative
LD50 Lethal Dose 50%: the dose that is estimated to kill 50 % of animals in acute
toxicity test
L-E Long-Evans (Turku/AB) rat strain: the most TCDD-sensitive rat strain
known
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mRNA Messenger RNA: formed from a DNA template by transcription
NF-κB Nuclear factor κB: universal transcription factor
OCDD Octachlorinated dibenzo-p-dioxin
p27Kip1 27 kDa protein that belongs to the family of cell cycle regulators called
cyclin-dependent kinase inhibitors, which cause cell cycle arrest in the G1
phase.
p60c-src 60 kDa protein encoded by c-src gene (see c-src)
PCBs Polychlorinated biphenyls
PCDDs Polychlorinated  dibenzo-p-dioxins and
PCDFs  polychlorinated dibenzofurans; belong to the family of  “dioxins”
PeCDD 1,2,3,7,8-pentachlorodibenzo-p-dioxin
PEPCK Phosphoenolpyruvate carboxykinase; a rate-limiting enzyme in
gluconeogenesis
PND Postnatal day; days from birth
REP Relative potency value; the potency ratio PCDD:TCDD value when the
value has been generated by a single laboratory examining a single endpoint
RNA Ribonucleic acid: a single-stranded nucleic acid
S-D Sprague-Dawley rat strain
SNP Single nucleotide polymorphism
TEF Toxic equivalency factor (see WHO-TEF)
TEQ Toxic equivalency quantity (see WHO-TEQ)
T3 3,3`,5-triiodothyronine; thyroid hormone
T4 3,3`,5,5`-tetraiodo-L-thyronine, thyroxine; thyroid hormone
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin: the most toxic congener of dioxins
UDP Uridine diphosphate
UGT UDP-glucuronosyltransferase; an enzyme involved in glucuronidation of e.g.
thyroid hormones in order to increase their solubility to water and aid in their
excretion.
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UGS Urogenital sinus; the small bodily cavity where the fetal urinary and genital
organ development begins
USEPA US Environmental Protection Agency
WHO World Health Organization
WHO-TEF WHO-Toxic equivalency factor: the factor that compares toxicity of other
dioxin-like compounds to TCDD, which has a TEF value of 1
WHO-TEQ Toxic equivalency quantity: a sum of dioxin congener concentrations
multiplied by their TEF values from the WHO-TEF standards (see WHO-
TEF)
XRE Xenobiotic responsive element (compare to DRE)
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1 General introduction and literature review
1.1 Introduction
The effects of dioxins1, especially the most toxic congener 2,3,7,8-tertrachlorodibenzo-p-
dioxin (TCDD; Fig. 1) on animals/humans have been extensively studied over the past 40
years. Such interest is maintained by the intriguing features of TCDD, including the many
toxic endpoints it influences (i.e. enzyme induction, teratogenicity, carcinogenicity,
immunosuppression, male reproductive defects), large inter-species and intra-species
variability in responses to TCDD, and its aryl hydrocarbon receptor (AHR) -mediated
toxicity.
Figure 1: Chemical structure of dioxin model compound TCDD.
Food is the main source of human exposure to dioxins, accounting for 90-98 % of the total
exposure (Fries 1995; Llobet et al. 2003; Parzefall 2002; Sweetman et al. 2000). As highly
lipophilic and biopersistent compounds, dioxins are deposited in animal fat and accumulate
in the food chain. In Finland the major source is Baltic herring, which is a commercially
important fatty fish. In recent years the efforts to control pollution have resulted in a
measurable reduction of human dietary exposures (Hays and Aylward 2003; Kiviranta et al.
2001; Llobet et al. 2003; Tsutsumi et al. 2001). The estimated human daily intake of
dioxins is about 1-3 pg/kg/day for adults, and is highly dependent on the diet (USEPA,
2000). However, food may become accidentally contaminated with dioxins and there are
some highly contaminated areas e.g. Baltic Sea.  The most recent food contamination
incident took place in 1999, when the control authorities in Belgium identified elevated
dioxin levels in beef and chicken (Huwe 2002). The source of contamination was found to
be PCB-containing oil mixed feloniously with recycled animal fats destined for animal
feed.
                                                
1
 Polychlorinated dibenzo-p-dioxins and dibenzofurans and dioxin-like polychlorinated biphenyls;
collectively called “dioxins”
O
O Cl
Cl
Cl
Cl
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Despite the enormous amount of data produced in the field of dioxin research, there is no
general agreement on the most sensitive and relevant endpoints for human risk assessment.
Neither is there an agreement on “safe” daily intake of dioxins from the diet. The U.S.
Environmental Protection Agency (USEPA) has based its assessment on low-dose linear
extrapolations of potential cancer risks using human data from highly exposed industrial
cohorts, and proposes that the acceptable daily dose of dioxins is equivalent to 0.001-0.01
pg TCDD/kg/day (USEPA 2000). USEPA has consistently derived much more stringent
tolerable daily doses of dioxins than have other U.S. and international agencies. Recently,
the World Health Organization (WHO) established the revisited tolerable daily intake of
dioxins as 1-4 pg/kg/day (van Leeuwen et al. 2000). Their assessment was based on
developmental defects, shown at low doses in animal studies. Additionally, in an opinion
by the European Commission Scientific Committee on Food (ECSCF), they identified
developmental effects on the male rat reproductive system as the most sensitive endpoints
and derived a tolerable weekly dose of 14 pg/kg/week for dioxins (ECSCF 2001).
Studies on animal models have indicated that genetic variability is a significant factor
affecting on effects of dioxin. In our laboratory, the highly TCDD-resistant Han/Wistar
(Kuopio, H/W) rat strain and TCDD- sensitive Long-Evans (Turku/AB, L-E) rats have been
used to study a wide variety of mechanistic aspects of dioxin toxicity (reviewed by
Pohjanvirta and Tuomisto 1994). The exceptional resistance of H/W rats to acute lethality
caused by TCDD is related to a mutation in Ahr and to an unknown allele “B” (Pohjanvirta
1990; Pohjanvirta et al. 1998; Tuomisto et al. 1999).  H/W rats are over 1000-fold resistant
to TCDD compared to the L-E rats. These resistance alleles were recently segregated into
new rat lines: line A rats have the H/W-type mutated Ahr, line B rats the “B allele”, and line
C rats no resistance alleles (Tuomisto et al. 1999). The availability of these new rat lines
permits studies on the influence of genetic factors on dioxin toxicity by analyzing the
influence of the deviant Ahr and B alleles on the sensitivity of the rats to various endpoints
of dioxin toxicity.
Variability in the sensitivity of animal strains to different dioxin congeners could influence
the utility of the concept of toxic equivalency factor (TEF), which has been used as the
basis of human risk assessment. In addition, the wide inter- and intra-species variation in
the potency and spectrum of dioxin toxicity leads to many assumptions in the extrapolation
of animal data to humans, thereby complicating the assessment of dioxin risk to humans.
The differences in sensitivity are mainly observed in acute, high-dose exposures, but there
is only a limited amount of information about their significance in low-dose and
developmental exposures.
Furthermore, increasing data on the sensitivity of developmental processes as well as the
recognition that nursing infants may have considerably high intakes of dioxins (estimated
on body weight basis), have questioned the use of cancer as the critical endpoint in dioxin
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risk assessment. Therefore, the developmental stage during exposure appears to be a highly
important factor in dioxin risk assessment.
This thesis provides further information on two important questions in dioxin toxicity: (1)
what is the influence of genetic factors (resistance alleles) on toxicity of dioxins and,
particularly on one of the most sensitive endpoints of dioxins, male reproductive toxicity
and  (2) how is dioxin sensitivity altered at different developmental stages?
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1.2 Dioxins and TCDD
The term “dioxin” refers in common language to the group of polychlorinated dibenzo-p-
dioxins (PCDD), -dibenzofurans (PCDF) and –biphenyls (PCB) (Figure 2).
Polychlorinated dibenzodioxin (PCDD)
Polychlorinated dibenzofuran (PCDF)
Polychlorinated biphenyl (PCB)
Figure 2: Chemical structures of PCDDs, PCDFs and PCBs.
The number of congeners and isomers is high; altogether there are 75 PCDDs, 135 PCDFs,
and 209 PCBs. The term isomer refers to compounds with the same empirical formulae, but
different localization of substituents in the molecule. The term congener refers to
compounds with same basic structure but different number of substituents. Incorporation of
chlorine to the lateral 2, 3, 7, and 8 positions of PCDD and PCDF congeners results in the
characteristic “dioxin-like” toxic and chemical effects. Additionally, only about one
twentieth of the PCBs have dioxin-like structure and toxicity. Those PCBs that are
unsubstituted (non-ortho) or monosubstituted (mono-ortho) in the ortho positions are
referred to as coplanar PCBs. (Safe 1986)
All 2,3,7,8-substituted PCDD and PCDF congeners induce similar biological effects
through the cytosolic aryl hydrocarbon receptor (AHR), except at vastly different doses
(Safe 1990; Van den Berg et al. 1998). Toxic equivalency factor (TEF) is used to normalize
for differences in pharmacokinetics and ligand binding, and to compare the potency of each
congener to that of TCDD, which is the most potent dioxin and generally used as a model
compound for this class of compounds. The TEF approach assumes that the compounds
must show a structural relationship to the PCDDs and PCDFs, bind the AHR, elicit AHR-
mediated biochemical and toxic responses, and accumulate in the food chain.
Typically, the rank order of potency is TCDD > pentachlorodibenzo-p-dioxin (PeCDD) >
hexachlorodibenzo-p-dioxin (HxCDD) > heptachlorodibenzo-p-dioxin (HpCDD) >
O
O
ClCl
ClCl
ClCl
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octachlorodibenzo-p-dioxin. The current WHO-TEFs (Table 1) are based on scientific
assessment of all available data (Van den Berg et al. 1998). Virtually all biological systems
studied so far follow this rank order. The relative potency (REP) value denotes the relative
potency of PCDDs compared to TCDD when a single laboratory examining a single
endpoint has generated the value.
Table 1: WHO-TEF values for mammals, fish and birds.
CONGENER TOXIC EQUIVALENCY FACTOR (TEF)
Mammals Fish a Bird a
2,3,7,8-TCDD 1 1 1
1,2,3,7,8-PeCDD 1 1   1 c
1,2,3,4,7,8-HxCDD      0.1 a     0.5        0.05 c
1,2,3,6,7,8-HxCDD      0.1 a       0.01        0.01 c
1,2,3,7,8,9-HxCDD      0.1 a         0.01 b      0.1 c
1,2,3,4,6,7,8-HpCDD      0.01         0.001        <0.001 c
OCDD             0.0001 a - -
“-“ Indicates no TEF value because of the lack of data
a) Limited data set
b) Cytochrome P450 (CYP) 1A induction in vitro
c) CYP1A induction in vivo after in ovo exposure
For all mammals, as well as for avian and fish species studied so far, the TEFs seem to be
applicable for lethality (van den Berg et al. 2000). A conspicuous exception to the universal
TEF concept is the acute lethality (follow-up time 42 days) of PCDDs in TCDD-resistant
H/W rats (Pohjanvirta et al. 1993, 1995). The H/W rats are more sensitive to the higher
chlorinated congeners, and their rank order for acute lethality is HxCDD > HpCDD >
PeCDD > TCDD. The unusual potency pattern of PCDDs in H/W rats in terms of acute
lethality implies that TEFs may be response specific.
Using the TEF concept, toxic equivalents (TEQs) can be calculated for any sample by
summing the normalized TEF consentrations of each dioxin-like compound. The TEQ
concentrations are thus calculated using the following equation:

 1[PCDDi x TEFi 2 [PCDFi x TEFi 3 [PCBi x TEFi].         [1]
The limitations associated with the TEF concept are the possible additive and antagonistic
interactions between dioxin-like and non-dioxin-like congeners, the differences in species
responsiveness, and differences in the shape of the dose-response curves for individual
AHR agonists (van den Berg et al. 2000). In addition, pharmacokinetic differences between
animal species can influence the TEF value. In spite of all assumptions and limitations of
the TEF concept, the prediction of TEQs for humans still seems to be the best approach for
risk management of dioxin-like compounds (van den Berg et al. 2000).
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Dioxins have no known industrial uses, but are formed as trace contaminants during waste
combustion and in the synthesis of products such as the chlorophenoxy acids and
chlorophenols that are used as herbicides, fungicides and mold inhibitors. In Finland the
worst known source is the chlorophenol containing wood preservative KY-5 that was
manufactured from 1948 until 1984 in a factory located along the Kymijoki river. High
concentrations of KY-5-derived dioxins accumulated in the Kymijoki river bottom
sediments (Korhonen et al. 2001). Chemical accidents may also result in the formation of
dioxins and lead to environmental or occupational exposure to these compounds. The most
severe accident took place in Seveso, Italy, in 1976, where an explosion of a chemical plant
producing trichlorophenol resulted in an escape of about 2 kg of TCDD to the environment
(Bertazzi et al. 1998).
Dioxins are highly lipophilic molecules and are generally recalcitrant to chemical and
biological degradation. The lipophilicity and stability of dioxins increase with increasing
ring chlorination. Because of their high lipophilicity and water insolubility, dioxins
concentrate in sediments and accumulate in tissue fat of fish, birds, and mammals (Isosaari
et al. 2002a, b; Kiviranta et al. 2002; Loonen et al. 1996). Dioxins are also universally
detected in human tissues, including mother’s milk and serum (Eskenazi et al. 2003, 2004;
Kiviranta et al. 1999; Wang et al. 2004). In breast fed infants the daily intake of dioxins is
even 1-2 orders of magnitude higher than in adults on a per body weight basis due to their
small body size (Päpke 1998). In addition, developing offspring can be exposed to dioxins
via the placenta (Chen et al. 2001; Hurst et al. 2000a,b; Kreuzer et al. 1997; Li et al. 1995).
The estimation for human half-life of TCDD in adults is 7 years, while in newborns the
estimation is only 0.4 years (Kreuzer et al. 1997; LaKind and Filser 1999; Pirkle et al.
1989; Poiger and Schlatter 1986).
In the average human population, the main exposure to dioxins occurs via food. In Europe
the main source is meat and dairy products. However, in Finland, the main source is Baltic
fish. The European Commission laid down the maximum limits for dioxin levels in fish and
other foodstuffs (ECSCF, 2001). For fish and fishery products the limit was set to 4 pg
TEQ/g wet weight, thereby practically banning the use of Baltic herring and salmon for
human consumption, as the major part of herring consumed by Finns seems to exceed the
limit value (Kiviranta et al. 2003). Finland and Sweden were, however, allowed a transition
period until 2006, at which time the limit value will be re-evaluated. This will be a
challenge for dioxin risk assessment, and calls for a careful consideration of the risks
associated with low-dose exposure to dioxins in the light of the beneficial effects of eating
fish.
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1.3 AH receptor, a key mediator of TCDD toxicity
AHR is known to mediate most of the biochemical and toxic effects of dioxins (Poland and
Glover 1980; Okey et al. 1994; Fernandez-Salguero et al. 1996; Lahvis and Bradfield 1998;
Tuomisto et al. 1999). The AHR is a soluble intracellular protein present in a wide variety
of animal species and tissues, although the amount is variable (Pohjanvirta and Tuomisto
1994; Hahn 2002). The AHR is bound in the cytoplasm to the molecular chaperone hsp90,
the co-chaperone p23 and to a 38kD tetratricopeptide repeat protein of the immunophilin
family (ARA9, AIP, Xap2) (Kazlauskas et al. 1999, 2000; LaPres et al. 2000; Ma and
Whitlock 1997; Petrulis et al. 2000).
The AHR binds the ligand in the cytosol, and the receptor-ligand complex is subsequently
translocated into the nucleus (Figure 3), where it dimerizes with the AHR nuclear
translocator (ARNT) and releases hsp90. The AHR and ARNT proteins are structurally
related, prototypic members of basic helix-loop-helix/PAS (bHLH/PAS) transcription
factors (Hahn 2002; Gu et al. 2000). The AHR-ARNT heterodimer binds to the dioxin-
responsive elements (DREs) upstream of the promoters that regulate the transcription of a
battery of xenobiotic metabolizing enzymes (Mimura and Fujii-Kuriyama 2003). These
enzymes include, but are not limited to cytocrome CYP1A1, CYP1B1 and CYP1A2, and
the phase II enzymes UDP-glucuronosyltransferase (UGT*01) and glutathione S-
transferase Ya (Nebert et al. 1993; Okey et al. 1994).
1.3.1 Regulation of AHR function
The AHR complex activates the gene encoding the AHR repressor (AHRR). The AHRR
inhibits AHR function by competing with AHR for dimerization with ARNT and for
binding to the DRE sequence (Mimura et al. 1999). The binding of AHRR-ARNT complex
to DRE does not activate the AHR regulated gene. The regulation of AHR function by
AHRR seems to be evolutionarily conserved across mammals and fish (Karchner et al.
2002). Additionally, after a single dose of TCDD in rats, the AHR is up-regulated after
initial depletion (Franc et al. 2001). However, the impact of AHR up-regulation on TCDD
responsiveness in animals is not known.
1.3.2 Other AHR ligands
Besides dioxins, polyaromatic hydrocarbons (PAHs) such as 3-methylcholanthrene,
benzo(a)pyrene,  benzoflavones, and related compounds bind to AHR. The PAHs bind to
AHR with relatively low affinity compared to TCDD. These compounds are formed during
combustion processes and may have been involved in the evolution of the AHR from a
developmental regulatory gene to a regulator of biotransformation enzymes (Hahn 2002).
Although AHR binds PCDDs and other xenobiotics selectively and with high affinity, it is
also likely to have endogenous ligands. On the other hand, AHR may play a biological role
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that is not yet understood. Possible endogenous ligands have been isolated from such
sources as human urine and porcine lung tissue (Adachi et al. 2001; Song et al. 2002).
Candidate endogenous ligands include lipoxin A(4) (Schaldach et al. 1999), bilirubin-
related compounds (Phelan et al. 1998; Sinal and Bend 1997), and tryptophan-related
compounds (Heath-Pagliuso et al. 1998). Tryptophan derivatives are suggested to function
as hormones that, mediate the neuro-endocrine signaling of light (Rannug et al. 2003).
Several dietary constituents can also act as ligands for AHR. For example, indolo[3,2-
b]carbazole (ICZ), a metabolite of indole carbinoles found in the gastrointestinal tract has
been shown to function as an AHR agonist. The AHR-binding affinity of ICZ is high, being
within the range of that for TCDD (Bjeldanes et al. 1991; Gillner et al. 1993). However, the
potency of TCDD to induce CYP1A1, as measured by ethoxyresorufin O-deethylase
(EROD) activity in Hepa-1 mouse hepatoma cells is 103-104 times higher than that of ICZ
(Chen et al. 1995). Additionally, ICZ is not able to elicit AHR mediated toxicity in rats
(Pohjanvirta et al. 2002). This lack of potency of ICZ in vivo is probably caused by factors
such as low bioavailability and rapid elimination.
Figure 3: Model for AHR mediated gene activation (modified from Denison and Nagy
2003). See text for explanations. Appreviations: AHR, Aryl hydrocarbon receptor;
ARNT, AHR nuclear translocator; hsp90, 90 kDa heat shock protein; DRE, dioxin
responsive element; XAP2, 38kD tetratricopeptide repeat protein of the immunophilin
family.
 DRE  CYP1A1
 ARNT
 mRNA
Other
factors?
Other genes
 DRE
 AHR
XAP2
hsp90
hsp90
 Proteasome
 Degradation
Exogenous and
endogenous ligands
Endogenous ligands
 Translation New polypeptides
Other gene
products
Increased
cytochrome P4501A1
25
1.3.3 Physiological role of AHR
By generating AHR knock-out (AHRKO) mice it has been shown that the AHR plays an
important role in normal mammalian development. AHRKO mice have a smaller liver
(Fernandez-Salguero et al. 1995, 1997; Schmidt et al. 1996) and defects in the heart (Lund
et al. 2003; Thackaberry et al. 2002, 2003; Vasquez et al. 2003) and certain reproductive
organs (Benedict et al. 2000, 2003; Lin et al. 2001), as well as in the vascular (Lahvis et al.
2000) and immune systems (Fernandez-Salguero et al. 1995, 1997; Gonzalez et al. 1995).
AHR may also be involved in the hepatic accumulation of retinoids (Andreola et al. 1997,
2004). Many other phenotypic changes in AHRKO mice are manifested only as the animal
ages, implying more rapid aging in AHRKO mice compared to wild-type mice (Fernandez-
Salguero et al. 1997; Gonzalez and Fernandez-Salguero 1998).
1.3.4 Other possible mediators of TCDD toxicity
In addition to the basic AHR-mediated mechanism described above, other mechanisms by
which the biological effects of dioxins are mediated have been suggested. Signal
transduction through cellular factors such as tyrosine kinase p60src, retinoblastoma protein,
steroid receptors, nuclear factor -κB (NF-κB), and hypoxia-inducible factor 1α (HIF1α)
has been shown to be modulated by TCDD in a manner independent of the transcriptional
activation of AHR (Chan et al. 1999; Enan and Matsumura 1996; Enan et al. 1998; Ge and
Elferink 1998; Gradin et al. 1996; Klinge et al. 2000; Ohtake et al. 2003; Puga et al. 2000).
1.4 Factors affecting toxicity of dioxins
A characteristic feature of TCDD is the dramatic difference in sensitivity to its acute
toxicity among different animal species. In laboratory mammals, the lethal dose 50%
(LD50) values range from about 2 µg/kg in guinea pigs to more than 3000 µg/kg in hamsters
(Olson et al. 1980). Table 2 presents the LD50 values for some species and some strains of
the same species. No acute mortality has been reported among humans occupationally or
accidentally exposed to dioxin. The highest human TCDD exposure has been estimated to
be 15-20 µg/kg (Geusau et al. 2001).
Variation in the sensitivity of different species to TCDD is not due to appreciable
differences in the half-life of TCDD elimination from the body. For example, the half-life
of TCDD elimination from the whole body is estimated as 24-31 days in the rat (Rose et al.
1976), 30 days in the guinea pig (Gasiewicz and Neal 1979), and 11-12 days in the hamster
(Olson et al. 1980). Perhaps the most significant variable affecting TCDD
sensitivity/resistance is the genotype, and most probably the structure of AHR. Recent
studies have indicated that, in the TCDD-resistant hamster and TCDD–sensitive guinea pig,
the C-terminal ends of AHR differ, leading to differences in the transactivation properties
of AHR (Korkalainen et al. 2000, 2001). Although these wide differences in sensitivity
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have primarily been reported for acute, high-dose effects, they may exert major difficulties
in interspecies extrapolations. Therefore, a crucial question for dioxin risk assessment is
whether these sensitivity differences also exist in low-dose outcomes such as in
developmental defects.
Table 2: LD50 values of TCDD for different animal species and strains (males only).
Species/Strain LD50 (µg/kg) Reference
Lake trout sack fry 0.074 (Walker et al. 1996)
Guinea pig 2 (McConnell et al. 1978)
Rhesus monkey 70 (McConnell et al. 1978)
Hamster 3000 (Olson et al. 1980)
Mouse, C57BI/6 180 (Chapman and Schiller 1985)
             DBA/2 2600 (Chapman and Schiller 1985)
Rat, Long-Evans 18 (Pohjanvirta et al. 1993)
        Han/Wistar > 9600 (Unkila et al., 1994)
        Line A > 10000 (Tuomisto et al. 1999)
        Line B 830 (Tuomisto et al. 1999)
        Line C 40 (Tuomisto et al. 1999)
1.4.1 Genetic factors
There is a great difference in sensitivity to acute lethality among the different strains of the
same species. The molecular basis for these differences appears to be associated with the
polymorphism of the AHR. The differences in sensitivity to TCDD may be described by
differences in TCDD potency and/or efficacy to induce toxic effects. Potency is a measure
of the concentration or dose of TCDD that produces a toxic response (i.e. ED50), while
efficacy characterizes the magnitude of effect induced by TCDD.
Animal models
C57BL/6J and DBA/2J mice. Poland and Glover (1975) found a 10- to 14-fold difference
in TCDD susceptibility between the Ah-responsive C57BL/6J mice and the less responsive
DBA/2J mice. The C57BL/6J mice have a wild-type Ahrb allele, resulting in the presence of
a high-affinity AHR. In DBA/2J mice the non-responsive Ahrd allele results in a
structurally altered receptor with lower affinity for the ligand (Ema et al. 1994; Okey et al.
1989).
The 10-14 –fold difference in TCDD potency to induce acute lethality between C57BL/6
and DBA/2 mouse strains is also shown in non-lethal endpoints, including CYP1A1
induction (Chapman and Schiller 1985; Ema et al. 1994; Okey et al. 1989; Poland and
Glover 1980). However, TCDD efficacy was only slightly affected. Similarly, in C57BL/6J
mice congenic at Ahr locus, the potency difference in acute lethality segregated with the
Ahr allele and the same difference was also seen in body weight and organ weight changes
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as well as clinical pathology (Birnbaum et al. 1990). But again, the efficacy was only
slightly affected.
AHRKO mice. Three independently generated Ahr knockout mouse strains have been
generated (Fernandez-Salguero et al. 1995; Mimura et al. 1997; Schmidt et al. 1996).
AHRKO mice are resistant to toxic effects of TCDD including acute lethality and
developmental defects (Fernandez-Salguero et al. 1995, 1996; Lin et al. 2001; Mimura et
al. 1997). However, at high doses of TCDD, AHRKO mice display retinoid accumulation
in liver and abnormal vascular structures in liver and kidney (Lahvis et al. 2000).
Furthermore, placental exposure to TCDD causes an increase in prenatal mortality in
AHRKO fetuses (Mimura et al. 1997; Peters et al. 1999). These findings suggest the
presence of a novel, alternative pathway for TCDD toxicity.
Han/Wistar and Long-Evans rats. Another useful model, discovered in our laboratory, is
the large intraspecies variation between the sensitive Long-Evans (Turku/AB; L-E) and the
resistant Han/Wistar (Kuopio; H/W) rat strains to the lethality of TCDD. The LD50 value
for H/W rats (>9600 µg/kg) may be even 1000-fold larger than that of L-E rats (18 µg/kg)
(Unkila et al. 1994; Pohjanvirta et al. 1993). The apparent molecular weight of AHR (~106
kDa) is similar in L-E rats and Sprague-Dawley (S-D) rats, but is smaller (~98 kDa) in H/W
rats (Pohjanvirta et al. 1999). The reason for the smaller size proved to be a
deletion/insertion-type change in the 3´ end of exon 10 in the cDNA (Pohjanvirta et al.
1998). The deletion has resulted in loss of 343 amino acids in respective protein. Two
diverse insertions, a shorter inversion (29 bases), and a longer insertion (134 bases) variant
contained a misplaced translation termination codon (UAA) in their sequence.  These gene
sequences translate into the same protein with a total loss of 38 amino acids. However, the
binding affinity of TCDD to AHR did not differ between these strains (Pohjanvirta et al.
1999).
Line A, B and C rats. Tuomisto and coworkers used conventional cross-breeding to
segregate the resistance alleles, Ahrhw and the unknown gene B, of H/W rats into different
rat lines designated A, B and C (Tuomisto et al. 1999). Line A has the mutated Ahrhw allele
and the wild-type B allele (genotype Ahrhw/hw, Bwt/wt). Line B lacks the resistant Ahrhw allele,
but is homozygous for Bhw (Ahrwt/wt, Bhw/hw). Line C possesses neither of the resistance
alleles (Ahrwt/wt, Bwt/wt). Lines A, B and C exhibit highly different LD50 values for TCDD
(Table 2). Line A rats are as resistant as H/W rats, line C rats almost as sensitive as L-E
rats, and line B rats have intermediate resistance (Fig. 4).
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Figure 4: Mortality dose-responses for TCDD in male H/W, L-E and line A, B, and C
rats (modified from Tuomisto et al., 1999).
Endpoint-dependent resistance
As is different from the mouse model, in H/W and L-E rats as well as in line A, B and C
rats the vast sensitivity difference seen in acute lethality, was not observed in all short-term
effects of TCDD. CYP1A1 expression and thymic atrophy are similarly induced between
the TCDD-sensitive and -resistant rats (Pohjanvirta et al. 1988; Tuomisto et al. 1999;
Tuomisto 1999). However, the resistance alleles greatly reduced the sensitivity the TCDD-
induced increase in serum bilirubin.
Genetic variation in humans
As indicated previously, genetic variation in the AHR leads to differences in sensitivity to
biochemical and toxic effects of dioxins in laboratory animals. In human Ahr, six single
nucleotide polymorphisms (SNPs) have been identified, four of which result in changes in
the amino acid sequence of the AHR protein. The majority of these SNPs locate in exon 10,
which covers the major portion of the C-terminal transactivation domain (Cauchi et al.
2001; Harper et al. 2002; Kawajiri et al. 1995; Smart and Daly 2000; Wong et al. 2001).
The impact of AHR polymorphism on human health is not clear, but most studies have
been unable to connect specific AHR alleles either to CYP1A1 expression/induction, lung
cancer incidence or chloracne (Anttila et al. 2000; Cauchi et al. 2001; Kawajiri et al. 1995;
Wanner et al. 1999). Interestingly, a recent study shows that a combination of two or three
of these SNPs prevents the TCDD-dependent CYP1A1 induction in vitro (Wong et al.
2001). The potential clinical significance of this finding, to cancer risk, or other toxic
effects remains to be determined.
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1.4.2 Developmental stage
Acute toxicity
Acute toxicity data that address the question of age at the time of exposure as a factor
affecting toxicity are insufficient. In most acute toxicity studies sexually mature, adult
animals have been used. However, it is generally believed that young animals are more
susceptible to biological and toxic effects of TCDD than adults are. Therefore, it is
important to elucidate the sensitivity at various ages, and the possible sensitivity differences
of young animals of different animal species/strains to dioxins. If a sensitivity difference
between young and adult animals exists, development of resistance during maturing could
further explain the resistance.
Developmental toxicity
More data are available to compare the sensitivity of TCDD exposure during the prenatal
and neonatal periods of life. Strain differences in adulthood are poor predictors for strain
differences in embryo/fetal mortality, and the potency of TCDD in prenatal mortality tends
to be more similar across species (Peterson et al. 1993). The LD50 of TCDD in adult
hamsters and guinea pigs is >3000 and 2 µg/kg TCDD, respectively, the difference being
over 1500-fold. However, there is only 12-fold difference in the maternal dose of TCDD
causing increased prenatal mortality in hamster and guinea pig embryo/fetus (18 and 1.5
µg/kg TCDD, respectively) (Olson and McGarrigle 1992). Similarly, the 1000-fold
difference in acute lethality to TCDD between L-E and H/W rats is clearly narrowed when
TCDD is administered during gestation (Huuskonen et al. 1994).
Critical window of sensitivity during the prenatal period
The time period during which the embryo/fetus is exposed to TCDD is an important
determinant of prenatal mortality (Peterson et al. 1993). A single maternal dose of 24 µg/kg
TCDD given on gestation day (GD) 6 significantly increases prenatal mortality in C57BL/6
mice compared to vehicle control, but there is only little or no increase in prenatal mortality
when TCDD is administered on day 8 of gestation or later (Couture et al. 1990). Similarly,
there are critical periods of sensitivity to dioxin-induced developmental toxicity other than
lethality. In mice, the critical window of sensitivity for an increased incidence of cleft
palate is between GD6-12, and no cleft palate occurs when mice are exposed to TCDD on
GD14 (Couture et al. 1990). Hydronephrosis on the other hand, can still be produced when
TCDD exposure first occurs a few days after birth (Couture-Haws et al. 1991).  The
development of the ventral prostate and epididymis in male rat offspring is most affected if
the maternal exposure takes place between GD15-18, compared to exposures on GD 8 or
after birth (Bjerke and Peterson 1994; Gray et al. 1995; Ohsako et al. 2002).
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1.5 Biochemical and toxic endpoints of dioxins
In laboratory animals, TCDD causes a wide spectrum of toxic responses including lethality,
wasting, liver toxicity, metabolic disruption, enzyme induction, immune impairment,
gastrointestinal and urinary tract lesions, endocrine disruption, reproductive toxicity,
teratogenesis and cancer (Birnbaum 1994; Birnbaum and Tuomisto 2000; Bock 1993;
IARC 1987; Pohjanvirta and Tuomisto 1994). Developmental effects (development of
immune, nervous, and reproductive systems) appear to be the most sensitive adverse effects
of TCDD exposure. The effects of TCDD on tooth development, bone quality and
mechanical strength as well as on bile pigments have been recently studied in our
laboratory (Jämsä et al. 2001; Kattainen et al. 2001; Miettinen et al. submitted; Niittynen et
al. 2003; Viluksela et al. 2002).
There appear to be only a few reports of acute or chronic toxic responses in humans from
background dioxin body burdens generated with normal dietary habits. The Finnish
background exposure via mother’s milk was shown to increase mineralization defects of
first permanent teeth in children (Alaluusua et al. 1993).
By contrast, many epidemiological studies have reported various adverse effects following
accidentally or occupationally high dioxin exposure (reviewed by Greene et al. 2003;
Kogevinas 2001; Mukerjee 1998; Sterling and Arundel 1986). The human health effects
associated with high dioxin exposure include behavioral alterations (Lai et al. 2002) and
skin disease (Guo et al. 1999). Different types of cancer are also associated to dioxin
exposure (Birnbaum and Fenton 2003; Huff et al. 1994; IARC 1997; Yu et al. 2000),
although contradictory data was obtained in recent study in Finland (Tuomisto et al., 2004).
There are only limited data on reproductive and developmental effects in humans exposed
to dioxins. Maternal exposure to dioxins has been associated with miscarriages, and
stillbirths (Constable and Hatch 1985). Also an increase in abnormal sperm number has
been reported in man (Guo et al. 2000). Paternal exposure to dioxins has been associated
with change in boy-to-girl sex ratio (Mocarelli et al. 2000).
However, it is important to notice that these populations have been exposed to 10-1000 -
times higher concentrations of TCDD than the general population. In addition, it is
important to note that humans are typically exposed to mixtures of chemicals, whereas
laboratory animals have been mainly exposed to purified dioxins. Especially in
occupationally exposed cohorts dioxins have been characteristic impurities of main
chemicals, such as chlorophenols and chlorophenoxyacids, and much higher exposure to
the main chemicals may be a significant confounding factor. These facts may explain why
the results of epidemiological studies appear to be inconsistent for most effects other than
dermatological effects (Kogevinas 2001).
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More details on some biochemical and toxic endpoints of dioxins based on animal studies
are presented below.
1.5.1 Acute lethality
There are many characteristic features in TCDD-induced lethality. TCDD is extremely
toxic to some animal species and strains, therefore, it is sometimes considered as the most
potent and potentially lethal, man-made chemical. Interspecies and intraspecies differences
in the acute lethality of TCDD are over 1000-fold as discussed above (Table 2).
Furthermore, typical for TCDD toxicity is the delayed manifestation of lethality after acute
exposure. The time lapse before death extends from one week up to 8 week from TCDD
exposure (Pohjanvirta and Tuomisto 1994). Although many years have been spent in
studying the ultimate mechanism of TCDD–induced lethality, it is still poorly understood.
1.5.2 Wasting syndrome
The wasting syndrome is characterized by a dramatic body weight loss, mainly due to
hypophagia (Kelling et al. 1985). However, in rats parenteral feeding prevented the weight
loss, but the rats still displayed similar latencies before death, as did their ad libitum –fed
partners (Seefeld et al. 1984; Gasiewicz et al. 1980). It was concluded that wasting might
be one cause of lethality, but not the only one. Depending on the dose, the decrease in feed
intake can be dramatic and irreversible, or only temporary (Pohjanvirta et al. 1993; Seefeld
et al. 1984). The mechanism of this quite unusual and drastic body weight loss is still
uncertain.
1.5.3 Thymus atrophy
Thymus atrophy is one of the most characteristic effects of TCDD exposure and occurs in
most animal species studied (Pohjanvirta and Tuomisto 1994). In rats, thymus atrophy
occurs at acutely toxic doses slightly lower than those resulting in body weight loss, but
higher than those already inducing CYP1A1 activity. The exact mechanism by which
TCDD induces thymus atrophy remains unclear. The possible hypotheses are: 1) TCDD
causes thymus atrophy by destroying committed prethymocytes (Fine et al. 1989, 1990), 2)
TCDD inhibits the intrathymic T cell development (Kerkvliet and Brauner 1990), 3) TCDD
kills immature thymocytes by initiating apoptosis (Kamath et al. 1997; McConkey et al.
1988). A most interesting and recent study showed that p27Kip1 gene is involved in the
inhibition of thymocyte proliferation (Kolluri et al. 1999). The induction of Kip1 by TCDD
in cultures of fetal thymus glands inhibits thymocyte proliferation.  This effect of TCDD is
largely absent in the thymic glands from Kip1-deficient mice (Kolluri et al. 1999).
1.5.4 Typical responses of selected biochemical markers to TCDD
EROD induction
CYP1A1 is a phase I xenobiotic metabolizing enzyme. Induction of CYP1A1 enzyme
activity reflects increased transcription of the CYPIA1 gene and the gene is regulated by
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AHR (Okey et al. 1994; Whitlock 1999). In the rat, CYP1A1 preferentially catalyzes the O-
dealkylation of 7-ethoxyresorufin. Thus, the activity of CYP1A1 is usually measured as
ethoxyresorufin-O-deethylase (EROD) activity (Parkinson 1996). Induction of the CYP1A1
enzyme is an extremely sensitive marker for exposure to TCDD and other PCDDs. It has
been possible to detect increased CYP1A1 mRNA levels following a single dose of as low
as 1 ng/kg TCDD in rats (vanden Heuvel et al. 1994).
Serum bilirubin
Bilirubin is formed in the catabolism of heme molecules in erythrocytes, myoglobin,
cytochromes and peroxidases (Bissell 1975). Serum bilirubin is greatly and rapidly (within
one day) elevated in rats after TCDD exposure (Unkila et al. 1994; Pohjanvirta et al. 1995).
Both total and conjugated bilirubins are increased, but their ratio is not affected implying
that the increase in serum bilirubin is due to increased formation of bilirubin, and not due to
decreased clearance.
Aspartate aminotransferase (ASAT)
Serum ASAT activity is dose-dependently increased after TCDD treatment. In TCDD-
treated (50 µg/kg) L-E rats the increase was up to five-fold while H/W rats showed no
increase (Pohjanvirta et al. 1995). Striated muscle, myocardium and liver are the main
sources of ASAT and it is normally little present in plasma, bile, cerebrospinal fluid and
saliva (Panteghini 1990).
Free fatty acids (FFAs)
When energy is needed, triglycerides stored in fat cells are hydrolyzed to glycerol and
FFAs by a specific hormone-sensitive tissue lipase. Mobilization of FFAs also occurs in
response to hypoglycemia or low levels of insulin in the blood. FFA mobilization in the
body may not be the primary response to TCDD exposure, but is more likely an adaptive
physiological response to the wasting syndrome. Serum concentration of FFAs was
increased in L-E rats compared to ad libitum –fed controls at a lethal dose of 50 µg/kg
(Pohjanvirta et al. 1989).
Thyroid homeostasis
Thyroid hormones are indispensable for growth, development and sexual maturation in
mammals. A deficiency of thyroid hormones results in decreased metabolic rate, alterations
in growth and development, disturbances in water and electrolyte balance, altered functions
of the central nervous system, skeletal muscles, and cardiovascular system, and changes in
lipid metabolism (Sterling 1979a, b).
In rats, TCDD induces the hepatic UDP-glucuronosyltrasferase (UGT) isozyme that
catalyzes the glucuronidation of thyroxine (T4), thereby increasing its elimination
(Bastomsky 1977; Curran and DeGroot 1991; Schuur et al. 1997). TCDD reduced serum T4
concentrations dose-dependently, and the reduction was seen already within 24 hours
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(Pohjanvirta et al. 1989). After four days the decrease was significant at a dose of 5 µg/kg
in both L-E and H/W rats. Pair-feeding studies revealed that decreased feed intake and
hypophagia might partly contribute to the reduction in serum T4 (Gorski et al. 1988).
The decrease in serum T4 concentration in rats is reproducible from one study to another,
but the effect of TCDD on serum T3 concentration seems to be highly variable among
different studies ranging from no change (Gorski and Rozman 1987; Rozman and Greim
1986), to a decrease (Potter et al. 1986), or an increase (Bastomsky 1977).
1.5.5 Male reproduction
Adult exposure
When TCDD is administered to sexually mature laboratory animals, it is known to reduce
testis weight, cause abnormal testicular morphology, decrease spermatogenesis, and impair
male reproductive performance (Chahoud et al. 1989, 1992; reviewed by Peterson et al.
1993). These effects may result, at least in part, from the reduction in plasma testosterone
and 5α-dihydrotestosterone (5α-DHT) levels. A decrease in circulating androgens was
observed in highly exposed adult rats within 24 hours (Moore et al. 1985, 1989), and the
pituitary-gonadal axis was involved (Moore et al. 1991). The ED50 for the androgenic
deficiency characterized by decreases in plasma androgen concentration and accessory sex
organ weights is approximately 15 µg/kg TCDD (Moore et al. 1985).
Perinatal exposure
In utero and lactational exposure to TCDD during organogenesis results in multiple effects
on the developing offspring (Birnbaum and Tuomisto 2000). Increased attention has been
paid to these effects, since they are elicited at very low doses. Among the key findings are
the male reproductive effects (Peterson et al. 1993; Roman and Peterson 1998).
Normal male gonad and reproductive duct system development in the mouse.  Gender
is established at the time of conception mainly by sex chromosome constitution, which
controls the subsequent differentiation of the gonads, the internal genital duct system and
external genitalia (Jameson et al. 2003). A gonadal primordium is first detected at GD11,
but the fetal gender is still indistinguishable. Around GD13 the developing gonads show
first evidence of sexual dimorphism, and Leydig cells within the fetal testes differentiate
and, synthesize and secrete testosterone (Staack et al. 2003).
Testosterone production stimulates the development of the Wolffian ducts to form the
epididymis, vas deference, and seminal vesicles.  The upper portion of the Wolffian duct in
the region of the testis differentiates into the epididymis at approximately GD18, the middle
portion forms the vas deference, and the caudal portion initiates the seminal vesicles on
GD16-17. (Staack et al. 2003)
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Prostate development begins as an epithelial budding from the urogenital sinus (UGS) at
approximately GD15-17. The buds emerge in a characteristic pattern that reflects the future
lobar organization of the glands; the ventral buds, anterior buds, and dorsolateral buds
(Cunha, 1972; Cunha et al. 1987b; Timms et al. 1994; Lin et al. 2003). Branching
morphogenesis of the prostate lobes continues post-natally and 90% of the ductal branching
is complete by day 10 of neonatal life (Sugimura et al. 1986).
TCDD effects on male reproductive development. Permanent adverse effects found in
male pups are delayed puberty, altered mating behavior, and decreased sperm counts (Faqi
et al. 1998; Gray et al. 1997; Mably et al. 1992a,b,c). Recently, Hamm and coworkers
(2003) demonstrated that exposure of rats to a mixture of dioxins, furans, and non-coplanar
PCBs resulted in a spectrum of male reproductive system effects similar to those of TCDD.
However, due to lower tissue concentrations of certain congeners, two to three times higher
doses than expected were required for comparable effects (Chen et al. 2001).
The most sensitive and reproducible effects have been seen on sperm numbers (Roman and
Peterson 1998); generally the epididymal sperm numbers are affected more than the daily
sperm production. The lowest maternal dose that reduced daily sperm production in 120-
day-old Holzman rats was 64 ng/kg on GD15 (Mably et al. 1992c). Gray and coworkers
reported significant decreases in ejaculated sperm numbers in adult Long-Evans hooded
rats after a maternal dose of 50 ng/kg on GD15 (Gray et al. 1997).
Additionally, weights of accessory sex organs are dose-dependently decreased by TCDD.
TCDD interferes with the development of ventral, dorsolateral and anterior prostate
(coagulating gland), as well as with seminal vesicle growth and morphogenesis (Bjerke et
al. 1994b; Gray et al. 1997; Hamm et al. 2000; Ko et al. 2002; Mably et al. 1992a; Roman
et al. 1995; Wilker et al. 1996). In Holtzman rats the reduction of ventral prostate weight is
observed at the maternal dose of 64 ng/kg on GD15 (Mably et al. 1992a). However, when
expressed relative to the body weight (measured as organ weight/body weight), 160 ng/kg
was the lowest dose with significant reduction in ventral prostate weight.
The sexual behavior of male rats is also altered after in utero and lactational exposure to
TCDD. The time for mounting receptive females was extended, achieving intromission was
more difficult and more thrusts were needed to achieve ejaculation (Mably et al. 1992b;
Gray et al. 1995). Feminization of sexual behavior of male rats was also reported (Bjerke et
al. 1994a; Mably et al. 1992b). However, this change was not observed in Long-Evans
hooded rats (Gray et al. 1995).
Despite the resistance to acute lethality of TCDD, the developing male reproductive system
of the hamster is sensitive to in utero and lactational TCDD exposure (Gray et al. 1995).
The exposure of Syrian hamsters on GD11 to 2 µg/kg TCDD resulted in delayed puberty,
and permanently decreased epididymal and ejaculated sperm counts. On the contrary, mice
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are less sensitive to TCDD-induced toxicity of developmental reproductive system than are
rats or hamsters (Theobald and Peterson 1997). Generally, the rat is the most sensitive
mammalian species to developmental male reproductive effects of TCDD; the sensitivity of
hamsters is about 1/10 that of the rat (Gray et al. 1995), and the sensitivity of mice is about
1/500 that of the rat (Theobald and Peterson 1997).
The effects of TCDD on developing male reproductive system resemble perinatal androgen
deficiency. However, the effects on androgen homeostasis in male pups are not congruent.
Some studies report a decrease in circulating androgen levels in the male offspring at birth
and in young adults (Mably et al. 1992a; Bjerke and Peterson 1994). However, many
studies with a similar dosing protocol have not been able to replicate these findings (Chen
et al. 1993; Cooke et al. 1998; Gray et al. 1997; Roman et al. 1995). Furthermore,
decreased expression levels of androgen receptor mRNA during puberty were reported in
ventral prostates of Holtzman rats exposed in utero and lactationally (Ohsako et al. 2001).
In the rat, the critical window for male reproductive effects is shown to be around GD15,
for example, the beginning of sexual differentiation (Ohsako et al. 2002). Hurst and
coworkers (Hurst et al. 1998; 2000) demonstrated that the concentration of TCDD in the
fetal tissue at the critical window is the important factor producing the toxic effects.
Statistically significant effects on sperm counts were seen after a dose of 50 ng/kg TCDD
on GD15, which results in fetal body burden of only 5.3 pg/g on GD16. At that time the
concentrations in the maternal tissue producing adverse effects in experimental animals are
nearly at the range of human background exposure to dioxin-like compounds.
1.6 Risk assessment of dioxins
Due to continuing concerns about dioxin-related health risks, a number of authorities have
assessed the risks of dioxins worldwide over past 20 years (reviewed by Larsen et al. 2000).
Strategies for risk assessment have changed during the past years, and different authorities
have used different approaches. Therefore, significant procedural differences exist among
different agencies and scientific organizations. Recently, most regulatory agencies, except
the USEPA, have set their tolerable daily intake level for dioxins into the range of 1-4 pg
TEQ/kg/day (Hays and Aylward 2003) (Table 3). The USEPA has concluded that the safe
doses are two to three orders of magnitude lower, 0.001-0.01 pg/kg/day (USEPA 2000).
The USEPA has used a linear, no-threshold dose-response extrapolation based on
carcinogenicity, while the other international agencies use risk extrapolation models that
assume an existence of a threshold dose and they use developmental defects as the critical
endpoint of toxicity. The tolerable daily intake value has a high political and public health
importance. In most European and North American countries the background dioxin
exposure is between 1 and 2 pg/kg/day, which is about 100-1000-times above the USEPA
tolerable human risk esposure daily intake level.
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The differences in risk assessments arise from the still existing uncertainties in dioxin
toxicity. The great difference in sensitivity to dioxins among various species, and the
uncertainty of human sensitivity exerts difficulties in species extrapolation. Also the
elimination half-lives varies greatly between humans and rodents. As mentioned, in humans
the elimination half-life is about seven years (Poiger and Schlatter 1986), while in rats the
half-life of TCDD is only three to four weeks (Geyer et al. 2002). Furthermore, the half-life
of TCDD in infants may be far less than in adults. Recently, a half-life of TCDD in
newborns was determined to be 0.42 years only (Kreuzer et al. 1997; LaKind and Filser
1999). Uncertainty (or safety) factors are used to compensate for intra- and inter-species
dynamic and kinetic variation, to protect certain sensitive groups with high exposure, such
as breast-fed infants, and to compensate for the possible gaps of knowledge.  It is also
recommended that the use of body burden as a dose metric rather than daily dose would
better recognize the effect of intra-species kinetic variation (DeVito et al. 1995).
Table 3: Comparison of recent derivations of tolerable intake levels.
Organization Endpoints LOAELa
(ng/kg)
Uncertainty
factors
TDI b
(pg/kg/day)
WHO, 1998
(van Leeuwen
et al. 2000)
Rat offspring
- male reproductive
system effects
- immunosupression
28-73
(maternal
body burden)
10
(composite)
1-4
USEPA, 2000
(USEPA 2000)
Range of effects
(BMD modeling for ED01)c
10-50 250-12500
(implied)
0.001-0.01
(implied)
ECSCF, 2001
(ECSCF 2001)
Rat offspring
- male reproductive
effects
- accelerated eye opening
- decreased anogenital
distance
(maternal
body burden)
40
80
20 (NOAEL)d
9.6
3.2
2
ATSDRe, 1998
(ATSDR 1998)
Monkey offspring
-    neurobehavioral effects
0.12 per day
intake in feed
(maternal)
90 1
a
 LOAEL = lowest observed adverse effect level
b
 TDI = tolerable daily intake
c
 Benchmark dose modeling for 1% effective dose that would increase the lifetime risk of
cancer mortality with 1%
d
 NOAEL = no adverse effect level
e ATSDR = agency for toxic substances and disease registry (USA)
The question of most sensitive effect to be used as the basis of risk assessment is also
unanswered. Cancer was generally used as the critical effect risk assessment performed
before 1998 (Hays and Aylward 2003). TCDD has been shown to be carcinogenic in
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experimental animals (Dragan and Schrenk 2000; Kociba et al. 1978), but so far,
epidemiological studies have been unable to reliably prove TCDD as a human carcinogen.
However, based on the possibility of carcinogenicity in humans and strong animal
carcinogenicity data, IARC has also concluded that TCDD is a human carcinogen (IARC
group 1; IARC 1997). Nowadays there is a growing concern over non-cancer effects of
dioxins, especially the effects on the developing immune, nervous, and reproductive
systems. The recent risk assessments other than USEPA have focused on these non-cancer
effects of dioxins, and thereby changed the most essential effect group from adults to
infants.
The present work aims to provide further information for the complex questions in dioxin
risk assessment.
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2 Aims of the study
The toxicity of dioxins is characterized by large inter- and intraspecies differences. The
differences in sensitivity seem to be dependent on genetic factors, but these factors and
their roles as determinants of dioxin sensitivity are only partly understood. Differences in
some, but not all endpoints of toxicity complicate the species-to-species extrapolation.
Recent toxicity studies in experimental animals and epidemiological studies in humans
have shown that very low doses of dioxins may result in developmental defects during the
sensitive periods of life. However, some key questions remain unanswered: What are the
sensitive periods for different low-dose endpoints? How are these endpoints affected by
genetic factors? The general aim of this thesis was to find answers to these questions.
The specific aims in each study were as follows:
1. To find out if the unusual lethal potency of HxCDD in H/W rats can be shown in short-
term non-lethal endpoints of dioxin toxicity and, furthermore, to characterize the resistance
of H/W rats to four PCDDs in the light of these endpoints. (I)
2. To describe the roles of rat H/W-type resistance alleles Ahrhw and Bhw in short-term non-
lethal endpoints of dioxin toxicity. (II)
3. To test, if the sensitivity to male rat reproductive defects after in utero and lactational
TCDD exposure is dependent on the resistance alleles Ahrhw and Bhw. (III)
4. To test, if the sensitivity to male rat reproductive defects after TCDD exposure in
adulthood is dependent on the resistance alleles Ahrhw and Bhw. (IV)
5. To investigate the role of AHR in the normal development of the male mouse accessory
sex organs, as well as in the effects of in utero and lactational TCDD exposure on the
development of these organs. (V)
6. To study the critical time window of sensitivity for various aspects of the development of
male mouse accessory sex organs and, consequently, to give insights into the mechanisms
by which TCDD exerts its effects. (VI)
7. To investigate the time-course of postnatal development of resistance to TCDD, and to
differentiate the roles of the resistance alleles Ahrhw and Bhw in the resistance development
in rat. (VII)
39
3 Materials and methods
3.1 Animals and animal husbandry
The rat strains and lines, and mouse strains used in the thesis are shown in table 4. For
LD50 information see table 2.
Rat studies (I-IV)
L-E and H/W rats, as well as line A, B and C rats were obtained from the breeding colony
of the National Public Health Institute (Kuopio, Finland) maintained in a specific pathogen
free (SPF) barrier unit. The animals are regularly subjected to health surveillance consisting
of serological and bacteriological screening as suggested by FELASA (FELASA 1996).
These surveys indicated that the animals were free of typical rodent pathogens. Tuomisto
and coworkers (1999) have described the breeding protocol used to develop rat lines A, B
and C.
Non-pregnant rats were housed in stainless steel wire-bottom cages, 5-6 rats per cage.
Pregnant and lactating females (III, IV) were housed singly in plastic cages that had wire-
mesh covers. Heat-treated aspen chips (Tapvei Co., Kaavi, Finland) were used as bedding
and nesting material. Following weaning, the pups were housed with same-sex littermates
similarly to pregnant females.
Rats received commercial rat chow (R36; Lactamin, Stockholm, Sweden) and tap water ad
libitum. The ambient temperature in animal room was 20±2°C, and the relative humidity
45±10%. The rats were kept under a photoperiodic cycle of 12 h light/ 12 h dark in an air-
conditioned animal room.
All rat procedures were conducted by protocols that were approved by the Animal
Experiment Committee of the University of Kuopio and the Kuopio Provincial
Government.
Mouse studies (V, VI)
AHRKO mice were generated as described by Schmidt and coworkers (1996) and
generously provided by Dr. Christopher A. Bradfield after being backcrossed to C57BL/6J
mice for six generations. Colonies of these mice, and those of C57BL/6J mice, were
maintained at the University of Wisconsin, School of Pharmacy animal facility (Madison,
WI, USA). The mice were backcrossed to C57BL/6J mice for three to five additional
generations. Dosing comparable percentages of dams with TCDD at each stage of
backcrossing minimized contributions of different genetic backgrounds to differences
between treatments.
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Mice were kept in a temperature-controlled room (24 ± 1°C) with 35 ± 4% relative
humidity, lighted from 0600 to 1800 hours. Mice were housed in clear plastic cages with
heat-treated chipped aspen bedding. Feed (5015 Mouse Diet, PMI Nutrition International,
Brentwood, MO, USA) and tap water were available ad libitum.
All mouse procedures were conducted under protocols approved by the University of
Wisconsin Animal Care and Use Committee.
Table 4: Description of rats and mice used in the study.
Animal Strain Ahr allele B allele TCDD acute
lethality
Rat H/W Ahrhw/hw Bhw/hw Resistant
A Ahrhw/hw Bwt/wt Resistant
B Ahrwt/wt Bhw/hw Semi-resistant
C Ahrwt/wt Bwt/wt Sensitive
L-E Ahrwt/wt Bwt/wt Sensitive
Mouse C57BL/6J Ahrb/b - Sensitive
AHRKO Ahr-/- - Resistant
  - Not known
3.2 Chemicals
TCDD, PeCDD, HxCDD and HpCDD were purchased from the UFA-Oil Institute (Ufa,
Russia); they were over 99% pure as confirmed by gas chromatography-mass spectrometry
(Vartiainen et al. 1995; Viluksela et al. 1998b).
In rat studies the PCDDs were weighed and dissolved in diethyl ether. A small volume of
diethyl ether was mixed with corn oil and the ether was let to evaporate. Dosing solutions
were mixed in a magnetic stirrer and sonicated for 20 minutes before dosing (I-IV, VII).
For mouse studies TCDD was dissolved in acetone and an adjusted volume of acetone was
mixed with corn oil to get a dissolved mixture of 95% corn oil/ 5% acetone.
Other chemicals and equipment used are given in the original publications. (I-VII)
3.3 Methods
3.3.1 Mating and weaning
Adult (12-15 week-old) female rats in estrus were mated with untreated males from 9 to 12
a.m. and vaginal smears were collected and examined for the presence of sperm. The day of
sperm detection in vaginal smears was considered as GD0. The offspring were weaned at
the age of 28 days. (III)
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Heterozygous (Ahr+/–) female mice at the age of 13-17 weeks were paired overnight with
Ahr+/– males. The next day was considered as GD0. The offspring’s were weaned at the age
of 21 days.  (V,VI)
3.3.2 Uterine implantation sites
At the time of weaning the dams were killed and the number of uterine implantation sites
was counted after staining the uteri with an ammonium sulfide solution (10%, v/v). For
each litter, the percentage of postimplantation loss was calculated by the following formula:
100 × (a - b)/a       [2]
where a is the total number of implantation sites, and b is the number of pups born. (III)
3.3.3 AHRKO mouse genotyping
Genotyping was done by polymerase chain reaction (PCR) analysis of ear punch tissue
taken at 10-16 days of age, as previously described (Benedict et al. 2000). Shortly, tissue
was lyzed with proteinase K at 65°C for 30 min with a 15 s vortexing after 15 and 30 min
incubation times. PCR was carried out from the lysate using the following primers: 1) Neo
F TTGGGTGGAGAGGCTATTCG, 2) Neo R CCATTTTCCACCATGATATTCG, 3)
AhrI3F TCTTGGGCTCGATCTTGTGTC and 4) TTGACTTAATTCCTTCAGCGG. The
conditions for PCR were as follows: 94°C, 2 min initial denaturation, 35 cycles of 94°C for
5 s, 60°C for 30 s, and 72° for 1 min, with a final extension at 72°C for 2 min. (V, VI)
3.3.4 Real-time reverse transcription- polymerase chain reaction (RT-PCR) for
mRNA quantification
Total RNA was isolated from prostate lobes using RNeasy Mini Kits (Qiagen, Valencia,
CA, USA) according to the manufacturer’s protocol. Oligo-dT primed first-strand cDNA
was synthesized using Omniscript reverse transcriptase (Qiagen) in 20 µl reactions
containing 500 ng total RNA, following the manufacturer’s instructions. Final reverse
transcription reactions were diluted to 100:l for storage and for real-time LightCycler
(Roche Molecular Biochemicals, Indianapolis, IN) quantitative PCR analysis. The exact
PCR and LightCycler protocols are described in detail in the original publication (V).
Primer sequences, product size, annealing temperatures, and gene descriptions are shown in
Table 5. (V, VI)
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Table 5: Primer sequences, product size, annealing temperatures and gene descriptions
used in quantitative Real-Time reverse transcription-PCR analysis.
Gene
(GeneBank
accession no.)
Primer sequences Temp
(°C)
Size* Description
Androgen
receptor
(emb X59590)
AATCTGGATGTGGAGAGAGC
AGAGAACAGAACACTAGCGC 60 166
Regulates patterns of gene expression
in response to testosterone and
dihydrotestosterone.
Cytokeratin 8
(emb X12789)
ACCAGGAGCTTATTAACGTC
AGGAGCTCATTCCGTAGCTG 65 204
Marker for fully structural
cytodifferentiation of luminal epithelial
cells (Fuchs 1988).
Cyclophilin
(emb X52803)
ATCACGGCCGATGACGAGCC
TCTCTCCGTAGATCCACCTGC 65 217
Commonly used normalization control,
mRNA expressed in all cell types
(Weisinger et al. 1999).
MP25
(emb X06246)
AGAGCCCAGAATGTCCTGGG
TTATCACGTGCTCTCCGTCC 65 214
Androgen-dependent secretory
glycoprotein produced by mouse
ventral prostate (Mills et al. 1987).
Probasin
(emb AF005204)
TTACATGTCGCATAGTACCTG
GGACAGAGACATGAAAGAGAAA 60 219
Androgen-dependent secretory protein
produced by dorsolateral and anterior
prostate (Johnson et al. 2000).
PSP94
(emb X16642)
TGCCACCATGGAAGCTTGGC
TAGCGTTGGTACAGCAGGTG 65 224
Prostate secretory protein of 94 amino
acids; protein primarily produced by
lateral prostate (Xuan et al. 1999).
Renin 1
(gb U89840)
ACTCGGTGACTGTGGGTGG
AGGTGGGAACCCCTGTTGTAG 65 220
Androgen-dependent protein highly
expressed in mouse anterior prostate
(Fabian et al. 1993).
SVS II
(dbj AK020661)
AAACAGAGGAAGACTTATCCC
AGGCGAGTCCTTGATATTGATC
60 237 Seminal vesicle secretion II protein;
protein specific to seminal vesicle
(Lundwall 1996).
*Size, product size (base pairs).
3.3.5 Daily sperm production and cauda epididymal sperm count
The frozen testes and cauda epididymides were homogenized for two minutes using Ultra
Turrax homogenizer (model T25 basic, IKA-WERKE GMBH & CO, Germany) in 0.9 %
saline, containing 0.05% Triton X-100 and 0.01% thimerosal. Homogenization resistant
sperm heads were counted using hemocytometer. (III,IV)
3.3.6 Testis morphometry
The left testes were fixed in bouin’s solution, containing saturated picric acid,
formaldehyde and glacial acetic acid (15:3:1; v/v), and cleared in 70% ethanol. Sections
were cut (5 µm) and stained with periodic acid-Schiff-haematoxylin (PAS-H). For all
control and highest TCDD dose animals, one section from one testis was examined. The
diameter of 10 stage VII/VIII seminiferous tubules was analyzed with computer assisted
light microscope using Stereo-Investigator and NeuroExplorer (MicroBrightField, VT) –
softwares. The numbers of Sertoli cells, spermatogonia, preleptotene spermatocytes,
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pachytene spermatocytes, and round spermatids were analyzed from five stage VII/VIII
seminiferous tubules using light microscope. (IV)
3.3.7 Biochemical assays and dental inspection
Androgen assays. For rat studies (III, IV) testosterone was measured from diethyl ether
extracts of serum samples by time-resolved fluoroimmunoassay (DELFIA, Wallac Ltd.,
Turku, Finland). In the mouse study (V) serum testosterone and 5α-androstane-3α,17ß-diol
(3α-diol) concentrations were determined from anhydrous ethyl ether extracts of serum
samples by radioimmunoassays (RIA), according to the protocol of the antibody supplier
(Endocrine Sciences, Calabasas Hills, CA, USA).
Ethoxyresorufin-O-deethylase (EROD) activity. EROD activity in liver S9 fraction was
assayed fluorometrically according to Kennedy and Jones (1994) with slight modifications.
(I, II)
Protein concentration. Protein concentrations were determined by the Bradford (1976)
method. (I, II)
Serum total T4 concentration. Serum total thyroxine (T4) concentrations were measured
using a coated tube T4 kit (Orion Diagnostica, Turku, Finland). The radioactivity was
counted using gammacounter (1272 CliniGamma Gammacounter, Wallac Oy, Turku,
Finland). (I)
Serum ASAT activity. ASAT activity assay was based on kinetic measurement using UV
photometric detection, and it followed the Scandinavian Committee on Enzymes (S.C.E.) of
the Scandinavian Society for Clinical Chemistry and Clinical Physiology recommendations
(1974). (I, II)
FFA concentration. Serum FFA concentrations were analyzed according to the method of
Shimizu and coworkers (1980). (I, II)
Total bilirubin concentration. Serum total bilirubin was measured using a modified diazo
ultramicromethod of Walters and Gerarde (1970). All these assays were performed with the
Kone Specific selective chemistry analyzer (Kone Instruments, Espoo, Finland). (I, II)
Tooth examination. Lingual attrition surfaces of lower incisors were examined for the
presence and severity of pulpal perforations (Alaluusua et al. 1993) using a
stereomicroscope. Severity of pulpal perforation was scored semi-quantitatively using a
scale 0-3 (0, no perforation; 1, initial perforation; 2, perforation; 3, perforation with pulpal
hemorrhage). (I, II)
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3.3.8 Efficacy and potency
Efficacy (or relative efficacy) describes the magnitude of effect and it was defined as a
relative change of the effect from the control level: (Emax-Emin)/Emin. Absolute efficacy
was defined as an absolute change: Emax-Emin. Efficacy ratio was defined as the relative
efficacy in one rat line divided by that in the reference line (usually line C). Sometimes
absolute efficacy ratio was calculated by using absolute efficacies. Potency was defined as
the inverse of ED50. (I, II)
3.4 Statistical analyses and curve fitting
Rat studies (I-IV, VII)
Treatment groups were compared by one-way analysis of variance (ANOVA), and the least
significant difference (LSD) test was used for post hoc comparisons. In the case of non-
homogeneous variances (according to Bartlett´s test, P < 0.01), the Kruskal-Wallis
ANOVA was used, followed by the distribution-free multiple comparison test (I) or Mann-
Whitney U test (II-IV, VII). P values less than 0.05 were considered significant.
Dose-response curves (I, II) were fitted assuming a shape of cumulative normal distribution
after logarithmic dose transformation and using the least square method with sequential
quadratic programming (SPSS 10.0 statistical program, SPSS Inc., Chicago, IL, USA). The
regression analysis was performed for all strains and all endpoints separately using the
following formula:
Ei(d) = Emin + (Emax – Emin) * Φ((d-µi)/σi) [3]
where Ei(d) is the observed effect at d = log(dose), Emin is the control effect, Emax is the
maximal effect, µi is log(ED50i), σi is log(GSDi) (GSD denoting for geometric standard
deviation), Φ is the cumulative standard normal distribution and i is the index for the four
congeners (I). The following restrictions were used for input values: ED50 0.01 – 3000
µg/kg; GSD >1.02; GSD < 50 (only II); Emin
For study II a probability that one estimate is smaller than the other was calculated by
randomly sampling values from the likelihood distributions of the two estimates. The
difference between strains was considered statistically significant if this probability was
smaller than 0.025 or greater than 0.975.
The data (II) were also modeled using nonlinear regression with a modified hyperbolic
curve, the Hill equation (DeVito et al. 1997; Holford and Sheiner 1981).
E(D) = Emin+ ((Emax-Emin) * Dn)/ED50n + Dn)                     [4]
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Where E(D) is the observed effect at D = dose, Emin is the control effect, Emax is the
maximal effect, ED50 = effective dose 50%, and n = Hill coefficient, the shaping factor.
Mouse studies (V, VI)
Analyses were conducted with the litter as the experimental unit. Treatment groups were
compared by one-way analysis of variance (ANOVA), and the least significant difference
(LSD) test was used for post hoc comparisons. In the case of non-homogeneous variances
(according to Levene´s test), Kruskal-Wallis ANOVA and the median test were used,
followed by the distribution-free multiple comparison test as the post-hoc test. P values less
than 0.05 were considered significant.
3.5 Experimental designs
The summary of the experimental design for each study is presented in Table 6.
(I) Structure-activity relationship and endpoint categorization
Five to six adult H/W and L-E rats were used per dose group. Rats were given a single oral
dose of one PCDD (TCDD: 0.03 – 100 µg/kg; PeCDD: 0.1 – 300 µg/kg; HxCDD: 0.3 –
300 µg/kg; HpCDD: 0.3 – 3000 µg/kg) or corn oil as a control (4 ml/kg). There were
separate control groups for each congener. On day 8 after exposure the rats were
decapitated with a guillotine. Liver and thymus were weighed and EROD activity was
analyzed from liver samples stored at –80°C. Serum samples were stored at -80°C. Serum
ASAT activity, and serum FFA, T4 and bilirubin concentrations were analyzed. Mandibles
were stored in 10% neutral buffered formalin and studied for incisor defects.
(II) Role of resistance alleles in acute non-lethal TCDD endpoint categorization
Five to six adult line A, B and C rats were used per dose group. Rats were given a single
oral dose of TCDD in corn oil, the TCDD doses being at approximate three-fold intervals
between 0.03-3000, 0.03-1000 and 0.03-100 µg/kg body weight in line A, B and C rats,
respectively. Control animals received corn oil vehicle (4 ml/kg). On day 8 postexposure,
rats were decapitated with a guillotine, and the analyses were carried out as in structure-
activity relationship study (I), except that serum T4 concentration was not analyzed.
(III) Role of resistance alleles in the effect of perinatal TCDD exposure on male
reproductive system
The pregnant rats were dosed by gavage, with a single dose of 0.03-1 µg/kg TCDD for
dose-response study or 1 µg/kg TCDD for time-course study. Control animals received an
equivalent volume of corn oil vehicle (4 ml/kg). Anogenital distance (AGD) and crown-
rump length (CRL) was measured on postnatal day (PND) 1 and 4. Body weights of dams
and offspring were determined weekly. Pups were weaned on PND28. For the dose-
response study all male pups were terminated on PND70 and for time-course study one or
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two male pups from each litter were terminated at different ages, PND14, 21, 28, 35 and 49.
Weight of testes, right epididymis (and cauda epididymis), ventral-, dorsolateral- and
anterior prostate, seminal vesicles and thymus were determined. Sperm counts were
analyzed from cauda epididymis and testis, and testosterone levels from serum.
Additionally, for PND35 terminated male pups the weight of lungs, heart, kidneys, liver,
salivary glands and spleen was determined.
(IV) Role of resistance alleles in the effect of adult TCDD exposure on male reproductive
system
Five to six adult line A, B and C rats were used per dose group. Rats were given a single
oral dose of TCDD in corn oil, the TCDD doses being at approximate three-fold intervals
between 0.1-1000, 0.1-300 and 0.1-30 µg/kg body weight in line A, B, and C rats,
respectively. Control animals received corn oil vehicle (4 ml/kg). On day 17 postexposure,
rats were anesthetized with CO2, and blood was collected with heart puncture. Serum was
separated and stored at –80°C until later analyses. Weight of testes, right epididymis (and
cauda epididymis), ventral prostate and seminal vesicles (emptied) were determined. Sperm
counts were analyzed from right testis and cauda epididymis, and testosterone levels from
serum.
(V) The development of accessory sex organs and the role of AHR
Pregnant mice were given a single oral dose of TCDD (5 µg/kg) or vehicle (95% corn
oil/5% acetone, 5 ml/kg) on GD13. Pups were weaned on PND21. Mice were euthanized by
CO2 overdose on PND35 or 90. Accessory sex organs were either frozen for mRNA
analyses, or placed overnight in Z-5 fixative (Anatech Ltd., Battle Creek, MI) for
histopathological analyses. The abundance of MP-25, probasin, renin-1, PSP94, SVS II,
androgen receptor, cytokeratin-8, and cyclophilin mRNA were analyzed by real-time
reverse-trancriptase PCR from the separate prostate lobes. The results are presented
separately for AHRKO and wild-type mice.
(VI) Critical window for accessory sex organ defects after TCDD exposure
Pregnant mice were given a single oral dose of TCDD (5 µg/kg) or vehicle (95% corn
oil/5% acetone, 5 ml/kg) on GD13. At birth, pups were fostered to dams from the same
treatment group or cross-fostered to dams from the opposite treatment group. Additional
dams were given a single oral dose of TCDD (5 µg/kg) on GD16; they were allowed to
keep their own pups. The analyses were carried out as in the AHR dependence study (IV),
except that PSP94 and SVS II mRNA levels were not analyzed. Additionally, all results
presented are from the wild-type mice.
(VII) Postnatal development of resistance to high-dose effects of TCDD
A pilot study was carried out in TCDD-resistant H/W rats. Newborn H/W litters were dosed
i.p., 4 ml/kg, with a single dose of 1000 µg/kg TCDD or corn oil vehicle at the age of 5, 7,
9, 11 and 14 days and survival of the pups was monitored for 42 days.
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In the main study newborn line A litters were given a single i.p. dose (4 ml/kg) of TCDD or
corn oil vehicle at the age of 2, 5, 8, 11, 14 or 17 days. Line B offspring were dosed at the
age of 5, 14, 28, 42 or 56 days. Line A pups received 1000 µg/kg TCDD, and line B male
and female pups 200 or 100 µg /kg TCDD, respectively. Offspring were weaned at the age
of 28 days. The condition and mortality were monitored for 42 days postexposure, and the
animals were weighed once a week for the whole duration of the experiment. All rats were
subjected to macroscopic examination after death or euthanasia. The weights of the kidneys
were recorded and the severity of hydronephrosis was evaluated semi-quantitatively by
assessing the renal pelvic dilatation. A subgroup of 6 male rats from each dosing group was
randomly selected from survivors on day 42 postexposure. These rats were followed up to
135 days, while the other rats were euthanized on day 42.
An additional group of line A litters was dosed at the age of 5 days according to the main
study protocol. The pups were euthanized eight days after dosing by decapitation and
thymus, testes, kidneys and livers were weighed. Liver samples were preserved in 10%
neutral buffered formalin for histological examination. In addition, the presence of
hydronephrosis was macroscopically scored as described above.
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4 Results
4.1 Resistance alleles and AHR as modifiers of TCDD toxicity
4.1.1 The exceptional relative sensitivity of H/W rats to higher chlorinated
dioxins is limited to acute lethality (I)
Dose-responses for short-term (8 days postexposure) non-lethal TCDD responses (body
weight loss, thymus atrophy, serum bilirubin, and liver EROD activity) followed the
normal rank order of potency in both L-E and H/W rats (I: Fig. 1-2). TCDD was the most
potent congener followed by PeCDD, HxCDD and HpCDD. There was no clear dose-
response in H/W rats for serum ASAT activity or FFA levels at the dose levels used.
However, there was no sign of exceptional potency of higher chlorinated dioxins either (I:
Fig. 3).
Overall the relative potency (REP) estimates for TCDD, PeCDD, HxCDD and HpCDD
were in fairly good agreement with the current WHO-TEF values in both L-E and H/W rats
(I: Table 4; Fig. 5), especially for body weight change, thymus atrophy, EROD induction,
and increases in serum bilirubin levels.
The dose-response data together with the REP values indicate that the exceptional relative
sensitivity of H/W rats to HxCDD and other higher chlorinated dioxins is limited to the
effects that result in acute lethality.
4.1.2 The efficacy ratio of 0.5 classifies the effects into type I and type II
categories (I, II)
Instead of potency, the efficacy expressed as a relative change ((Emax – Emin)/Emin)
turned out to be the most important factor for classification of non-lethal short-term TCDD
toxic effects into two different categories, type I and type II endpoints. The results with line
A, B and C rats showed that the Ahrhw is the most important factor decreasing the TCDD
efficacy, and the mechanistic difference between type I and II endpoints is linked to the
Ahrhw allele and thereby to the altered AHR transactivation domain. In contrast, the Bhw
allele has only a minor effect on efficacy when judged based on most endpoints.
Type II endpoints. H/W rats showed lower efficacy than L-E rats for TCDD-induced body
weight loss, serum ASAT activity, and serum concentrations of total bilirubin, fatty acids
and thyroxine (I: Fig. 2 and 3). For these endpoints the efficacy in H/W rats was less than
half of that in L-E rats (I: Table 4), and they were thus categorized as type II endpoints
(efficacy ratio < 0.5). The results with line A and C rats confirmed the validity of this
classification criterion. The efficacy ratios between line A and line C rats for these
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endpoints were also less than 0.5 (II: Table 2). Serum thyroxine concentration was not
analyzed in line A, B and C rats.
Type I endpoints. The efficacy for TCDD-induced thymus weight change, EROD activity,
and incisor tooth defects was similar in H/W and L-E rats, as well as in line A and line C
rats (I: Fig 1; Table 4, II: Fig 1; Table 2). These effects were categorized into type I
endpoints with more than 0.5 fold efficacy ratio between the resistant and sensitive rats.
4.1.3 TCDD-induced decrease in sperm numbers is modified by the rat
resistance alleles (III, IV)
In utero and lactational TCDD exposure (III)
TCDD consistently and statistically significantly decreased the ventral prostate weight (III:
Table 2), as well as anterior and dorsolateral prostate weights. Also sperm counts,
especially the cauda epididymal sperm count was a sensitive endpoint, being consistently
decreased after in utero and lactational TCDD exposure (III: Fig. 1).
Up to the age of 49 days the TCDD effects on male reproductive endpoints appeared quite
similar between the rat lines. At the age of 70 days the decrease in daily sperm production
and cauda epididymal sperm number seemed to me more pronounced in line B and C rats
than in line A rats, indicating that decrease in sperm numbers is modified by the resistance
alleles. The resistance alleles did not profoundly affect the sensitivity of the development of
male reproductive organ to in utero and lactational TCDD exposure.
TCDD exposure delayed the puberty-related increase in serum testosterone levels, which
were most severely depressed on day 49. Afterwards the levels approached the control
levels.
Adult TCDD exposure (IV)
Decreases in sperm parameters and ventral prostate weight were the most sensitive
endpoints observed after adult TCDD exposure. The effects were seen at doses that also
decreased the body weight, i.e. 10 µg/kg TCDD and higher in line A, B and C rats (IV;
Figs. 1, 3, 5). Serum testosterone levels were also decreased at the highest TCDD doses
(IV; Fig. 2). Testis weight was not affected and only a marginal decrease was observed in
epididymis, cauda epididymis and seminal vesicle weights.
The rat lines did not show clear sensitivity differences for the TCDD-induced decrease in
androgenic status. However, the resistance alleles did increase the resistance to the TCDD-
induced decrease in sperm numbers.
The highest dose of TCDD showed a tendency to decrease the number or Sertoli cells,
round spermatids, as well as pachytene- and preleptotene spermatocytes per tubulus in each
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rat line (IV; Fig. 4), and there were no sensitivity differences between the rat lines. The
number of spermatogonia per tubulus was not affected.
4.1.4 Most effects of TCDD on growth and functional development of male
accessory sex organs in mice are AHR-dependent (V)
The effects of TCDD on the growth and functional development of accessory sex organs,
analyzed on PND35 and 90, are summarized in Table 7. In general, the influence of TCDD
on growth and functional development of prostate lobes was dependent on the AHR. The
only exceptions from AHR dependency were the decreased luminal epithelial cell specific
gene expression in ventral and dorsolateral prostates, as well as decreased seminal vesicle
weight (V: Fig. 7), as these effects were observed also in TCDD-exposed AHRKO mice.
Serum androgen concentrations (V: Fig. 8), or androgen receptor expression (V: Figs.
2,4,6) were not significantly affected by Ahr null mutation and/or TCDD exposure.
Interestingly, TCDD exposure seemed to cause some re-specification of gene expression in
wild-type mouse ventral and lateral prostate lobes. In ventral prostate, the lateral prostate
specific PSP94 mRNA expression was increased by TCDD exposure (V: Fig. 2). In
addition, in certain TCDD-exposed wild-type and vehicle exposed knockout dorsolateral
prostates, the seminal vesicle specific SVS II mRNA was produced at least at a level that
was an order of magnitude greater than the highest level seen in any wild-type mouse
exposed to the vehicle (V: Fig. 6).
The Ahr null mutation plays a role in the development of the accessory sex organs, though
these effects are organ specific. The Ahr null mutation restrained the growth of the
dorsolateral prostate and delayed that of the anterior prostate (V: Fig. 3, 5). However, gene
expression and histology appeared normal. Also seminal vesicles were smaller in AHRKO
mice (V: Fig. 7), even though the histology appeared normal. No effect of the Ahr null
mutation was seen on the ventral prostate development.
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Table 7: Effects of TCDD on the growth and functional development of accessory sex
organs analyzed on PND35 and 90.
AHRWT +
TCDD
AHRKO +
CO
AHRKO +
TCDD
Ventral prostate Absolute weight ↓ a - b -
Relative weight ↓ - -
MP25 mRNA
   - relative to cyclophilin ↓ - -
   - relative to CK8 ↓ - ↓
CK8 relative to cyclophilin ↓ - -
Histology - - -
Dorsolateral prostate Absolute weight ↓ ↓
only PND35
-
Relative weight ↓ ↓ -
Probasin mRNA
   - relative to cyclophilin - - -
   - relative to CK8 ↓ - ↓
CK8 relative to cyclophilin - - -
Histology - - -
Anterior prostate Absolute weight ↓ ↓;
only PND35
-
Relative weight ↓ ↓;
only PND35
-
Renin-1 mRNA
   - relative to cyclophilin ↓ - -
   - relative to CK8 ↓ - -
CK8 relative to cyclophilin - - -
Histology - - -
Seminal vesicle Absolute weight ↓ ↓ ↑; PND35
↓; PND90
Relative weight ↓ ↓ ↑
Histology - - -
a
 Statistically significant (p<0.05) decrease ( ↓ ) or increase ( ↑ ) compared to wild
type vehicle control.
b
 No statistically significant effect compared to wild type vehicle control.
4.2 Developmental stage as a determinant of TCDD toxicity
4.2.1 The developing male rat reproductive system is more susceptible than
the adult reproductive system (III, IV)
The effects of TCDD on daily sperm production, cauda epididymal sperm reserve and
prostate weight were observed after the adults were given a dose of 10 µg/kg TCDD or
higher (IV). In utero and lactational TCDD exposure induced similar effects on sperm
parameters and prostate development after a maternal TCDD dose of only 0.3 µg/kg.
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Therefore, the male rat reproductive system is clearly more sensitive to TCDD during
perinatal development than in the adulthood.
4.2.2 The critical time window of TCDD sensitivity is prostate lobe specific in
mice (VI)
The effect of TCDD on ventral prostate growth (measured as weight of organ/body weight)
was mostly due to in utero exposure (VI: Fig. 1). Dorsolateral prostate and anterior prostate
growth was inhibited by both in utero and lactational TCDD exposure (VI: Fig. 2,3).
However, a combined in utero and lactational exposure was necessary for inhibition of
seminal vesicle growth (V: Fig. 4). Delaying the start of TCDD exposure from GD13 to
GD16 resulted in a smaller but significant reduction of ventral and anterior prostate weight
(VI: Fig. 1,3). However, the delay of TCDD exposure had no effect on the growth of
dorsolateral prostate or seminal vesicle (VI: Fig. 2,4).
The effect of TCDD on functional cytodifferentiation in different prostate lobes was
measured as androgen-dependent gene expression per cell; MP25 for ventral prostate,
probasin for dorsolateral prostate, and renin-1 for anterior prostate. The effect on ventral
prostate secretory cytodifferentiation was mostly due to in utero exposure, and that on
dorsolateral prostate approximately equally due to in utero and lactational exposure (VI:
Fig. 2, 3). The functional cytodifferentation of anterior prostate was inhibited regardless of
the timing of TCDD exposure (VI: Fig.3).
Structural cytodifferentiation was measured as a proportion of fully differentiated luminal
epithelial cells compared to all cells (cytokeratin 8:cyclophilin). In the ventral prostate, the
delay of the start of TCDD exposure from GD13 to GD16 significantly increased the
cytokeration 8:cyclophilin ratio (VI: Fig.1), indicating that the proportion of structurally
fully differentiated luminal epithelial cells was affected by the timing of TCDD exposure
between GD13-16. Structural cytodifferentiation was not affected in dorsolateral or anterior
prostate development (VI: Fig. 2, 3).
Altogether, the time during which the four organs are the most vulnerable to TCDD varies
from one organ to another. The most vulnerable periods during the growth and functional
development of accessory sex organs are presented in Table 8.
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Table 8: Critical windows of sensitivity of growth and differentiation of accessory sex organs
in mice.
Accessory
sex organ
Growth Structural
cytodifferentiation
Functional
cytodifferentiation
Developmental stages
affected
Ventral
prostate
GD13 – 16 GD13 - 19 GD13 - 16 Early bud stage and budding
Dorsolateral
prostate
GD16 – postnatal Not affected GD16 - postnatal Later prenatal processes a
Anterior
prostate
GD13 – 16 Not affected Postnatal Multiple processes
(prenatally and postnatally)
Seminal
vesicle
GD16 – postnatal - b - After rudiments appear
a
 Bud formation, bud elongation and/or duct formation.
b Not examined.
4.2.3 The time-course for development of resistance to mortality is different
in line A and in line B rats (VII)
Line A rats were fairly resistant to TCDD already two days after birth, and the full
resistance to acute lethality developed during the first week after birth for both males and
females. Line B rats did not attain complete resistance until at the age of 28 days in females
and 42 days in males. (VII: Fig. 1)
Line A males that survived through the 42-day period still died on average 80 days after
TCDD exposure (VII: Fig. 2; Table 1). Necropsies revealed that in addition to wasting most
rats suffered from severe liver damage and hydrothorax.
Body weight gain was decreased in both line A and B rats and settled below the control
level. The difference in body weight seen shortly after exposure remained fairly constant to
the end of the observation period (VII: Fig 3).
Hydronephrosis was observed with high frequency and severity in line A and B rats
exposed to TCDD as late as during the first two weeks of life (VII: Fig. 4). The time of
sensitivity to hydronephrosis of both line A and B rats appeared to be similar.
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5 Discussion
Although dioxins have been extensively studied for a number of years, there are still
remarkable uncertainties in the human risk assessment. Two crucial questions of the dioxin
toxicity discussed in the present thesis are: 1) the role of resistance alleles in a) the
validity of the TEF approach, and in b) TCDD toxicity, especially the male reproductive
effects, 2) the influence of the developmental stage at the time of TCDD exposure on the
outcome.
5.1 The role of resistance alleles and AHR (I-V)
Of the animal models generally used in mechanistic dioxin research, the C57BL6 / DBA
mouse model and the AHRKO model have been useful in demonstrating the dependence of
a variety of dioxin-induced toxic effects on the AHR signalling pathway as well as in
identifying those effects that are not mediated by AHR. On the other hand, our rat model
based on the resistance alleles proved to be useful in further characterisation of AHR
mediated effects by detecting genotype-dependent differences in sensitivity. Furthermore,
based on these sensitivity differences it was possible to divide AHR mediated effects of
dioxin into two mechanistically different categories, the type I and type II endpoints. This
animal model also indicated that the Ahrhw with mutated transactivation domain is an
important from the point of view of sensitivity differences. Although it is still premature to
estimate the potential significance of these findings for the human risk assessment, it is
highly interesting that also the first data to link genetic variability in the human AHR to
sensitivity differences in a dioxin-induced effect suggest that the transactivation domain
would be involved (Wong et al. 2001).
5.1.1 The validity of TEF approach (I)
Dioxin congener potencies in TCDD-resistant H/W rats are different from those typically
expected, because H/W rats are exceptionally sensitive to HxCDD in terms of acute
lethality (Pohjanvirta et al. 1993). By establishing the structure-activity relationships for
different endpoints of toxicity in this thesis it was possible to define the role of the H/W-
type resistance alleles in the characteristic non-lethal endpoints of dioxin toxicity. This
knowledge provides mechanistic information about the different endpoints, but it also
demonstrates the influence of these resistance alleles on the TEF approach.
The structure-activity relationships of PCDDs.
Despite the exceptional relative sensitivity of H/W rats to acute lethality caused by higher
chlorinated PCDDs, TCDD was found to be the most potent congener in inducing all
studied short-term non-lethal toxic effects, including body weight loss in H/W and L-E rats.
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Therefore, it appears that the abnormal potency of higher chlorinated PCDDs is limited to
acute lethality and the non-lethal toxic endpoints follow the normal rank order of potency
(DeVito et al. 1997; Hebert et al. 1990; Safe 1990; Weber et al. 1992); TCDD being the
most potent congener followed by PeCDD, HxCDD and HpCDD.
The results indicate that the exceptional potency of higher chlorinated PCDDs in H/W rats
is limited to acute lethality and to the high dose levels that cause lethality. This implies that
lethality is mechanistically different from the other, lower dose outcomes of dioxin-induced
toxicity and, therefore, HxCDD-induced lethality does not represent a direct manifestation
of the typical toxic effects of dioxins. Furhermore, this type of lethality can only be
observed in rats that are resistant to the characteristic TCDD toxicity (cf. Pohjanvirta et al.
1995), i.e. in H/W and in line A rats. This hypothesis is supported by our recent findings
indicating that at very high doses there are clear differences in the outcome of toxicity
between HxCDD and TCDD –treated rats (Simanainen et al. 2003). All rats that died from
HxCDD had an exceptionally pale liver, HxCDD reduced body weight more rapidly than
TCDD and, unlike TCDD, HxCDD caused diarrhea. In addition, the mean survival time
before death was only 14 days for HxCDD treated rats compared with 33 days for TCDD
treated rats. Interestingly, 10 mg/kg HxCDD caused lethality in H/W and line A rats, while
the same dose of TCDD did not.
Also two previous studies from our laboratory are in accordance with this interpretation of
the present findings. Firstly, based on observations at very high PCDD doses Pohjanvirta et
al. (1995) were the first to point out that there may be at least two distinct mechanisms of
PCDD toxicity. The predominant one is characteristic for TCDD and PeCDD, and the other
one is characteristic for HxCDD and HpCDD and can only be detected in animals resistant
to the primary mechanism. Secondly, Unkila et al. (1998) showed that in H/W rats a high
dose of HxCDD (5000 µg/kg 6 days before sampling) resulted in more profound body
weight loss and tryptophan homeostatsis disruption compared to the same dose of TCDD.
REP estimations and the current TEF values
The REP estimates for TCDD, PeCDD, HxCDD and HpCDD were found to be consistent
with the latest consensus WHO-TEF values (Table 1; I: Fig. 5). Only the REP estimate for
PeCDD deviated from the WHO-TEFs, and was closer to the previous TEF of 0.5 than to
the current TEF of 1. This is comprehensible considering that the TEF for PeCDD was
upgraded to 1 in the last WHO expert meeting based on in vivo liver tumor promotion data,
giving lower priority to all short-term data (Van den Berg et al. 1998).
Deviation of single REP estimates from consensus TEF values reflects the endpoint
prioritization dilemma in TEF determination. Each TEF is derived from a range of REP
estimates obtained from in vivo and in vitro studies. A recent study demonstrated that the
WHO TEFs for the PCDD/Fs are at the upper bound of the underlying REP distributions
(Finley et al. 2003). This tends to lead to conservative risk assessment. Finley and
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coworkers (2003) suggested that instead of using the point estimate TEFs, the use of REP
data distributions would allow more informed evaluation of variability and uncertainty in
dioxin risk estimates.
5.1.2 Short-term toxicity and male reproductive toxicity of TCDD (I - V).
The influence of genetic variation on human sensitivity to dioxins is largely unknown, but it
is expected to be significant, as the influence of genetic factors clearly influence the
variation of TCDD toxicity in experimental animals, e.g. in rats and mice. The roles of
genetic factors vary also among different endpoints of dioxin toxicity (Pohjanvirta et al.
1988; Tuomisto et al. 1999; I – IV).
Criteria for endpoint classification into type I or type II
Previous studies from our laboratory have shown that short-term toxic responses to TCDD
were either similar in H/W and L-E rat strains, or H/W rats were more resistant
(Pohjanvirta et al. 1988; Tuomisto et al. 1999). In this study the dose-responses for short-
term effects were determined, modeled and quantified in a systematic manner for the first
time and thereby it was possible to define the exact criteria for classification of different
endpoints (I, II). The major difference between the rat strains was in the efficacy seen in
certain endpoints. Efficacy is description of the magnitude of toxic response induced by
TCDD, while potency determine the concentration or a dose of TCDD that produce a toxic
response (i.e. ED50). The H/W:L-E efficacy ratio of 0.5 appeared to classify “clear” type I
and type II short-term endpoints (Table 9; I). Additionally, the studies on line A, B and C
rats confirmed the validity of efficacy as a classification criterion for type I and type II
endpoints in short-term toxicity studies (II).
Table 9: Classification of short-term PCDD endpoints in rats.
H/W:L-E
(line A:lineC)
efficacy ratio
Role of resistance
alleles, Ahrhw and Bhw
Typical endpoints
Type I > 0.5 No effect EROD induction, change in thymus
weight, incisor tooth defects
Type II < 0.5 Increase resistance Lethality, change in body weight,
serum ASAT activity, serum
bilirubin and FFA level
The role of Ahrhw allele. The Ahrhw proved to be the major factor decreasing TCDD
efficacy (II), indicating that the mechanistic difference between type I and II effects is
linked to the Ahrhw allele. The deletion mutation in Ahrhw is located in the transactivation
domain and thus the domains responsible for ligand and DNA binding as well as
heterodimerization are intact (Pohjanvirta et al. 1998). Therefore, the decreased ability of
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the Ahrhw to mediate PCDD toxicity in type II endpoints can be localized into steps beyond
DNA binding, i.e., into the AHR-dependent gene expression.
The C-terminus of AHR is required for the formation of functional AHR conformation that
increases promoter accessibility and facilitates promoter occupancy by different
transcription factors (Ko et al. 1996; Kronenberg et al. 2000). As the promoter sequences
and the transcription factor machinery vary among genes, the two types of endpoints imply
that the mutation in the Ahrhw selectively affects the formation of functional AHR
conformation as well as communication between enhancer and promoter, leading to altered
expression of different genes.
Another theory involves the possibility of two different AHR-mediated signaling pathways,
i.e. the AHR-ARNT-DRE –dependent pathway and the pathways that are independent of
AHR transcriptional activation. In fact, the concept of two different AHR mediated
signaling pathways has been previously suggested by Matsumura and co-workers
(Blankenship and Matsumura, 1997; Dunlap and Matsumura, 2000; Enan and Matsumura,
1996; Matsumura et al. 1997). Their data suggest that TCDD cause activation of tyrosine
kinases, in particular p60c-src kinase mediating at least a part of TCDD toxicity. Therefore, it
can be hypothesized that type I endpoints like CYP1A1 induction are mediated by AHR-
dependent activation of gene expression in the nucleus, i.e. the AHR-ARNT-DRE –
pathway, and type II endpoints are mediated by AHR-dependent tyrosine kinase pathway.
However, this theory presumes that the latter pathway is functional in all type II endpoints.
Previously, Dunlap and coworkers (2002) demonstrated that c-src knockout mice that do
not express c-src appear to be slightly more resistant to TCDD-induced depletion of
glycogen storage and down-regulation of phosphoenolpyruvate carboxykinase (PEPCK),
which are changes associated with wasting syndrome (Viluksela et al. 1995; Weber et al.
1995).
The role of Bhw allele. The Bhw allele had only a minor influence on TCDD efficacy, and
the classification into either type I or type II endpoints was not clear. Therefore, it is
concluded that a mechanism specifically associated to the Ahr genotype is necessary for the
endpoint classification. However, as the responses in line B rats differ from those in line C
rats, the B allele is somehow involved in the mechanistic pathway of TCDD toxicity.
As the identity of B allele has not yet been determined, it is hypothesized that Bhw could be
a protein participating in the AHR signaling pathway. Despite the fact that ARNT has
several different products of alternative splicing of mRNA, there were no differences in
relative expression levels of the ARNT variants between H/W and L-E, or among the line
A, B and C rats (Korkalainen et al. 2003; Korkalainen, unpublished results). The AHRR
was also considered as a possible candidate for Bhw, but recent results suggest that AHRR
does not contribute to dioxin sensitivity differences observed in H/W and L-E rats
(Korkalainen et al. 2004).
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Further characterization of type I and type II endpoints
Even though type II endpoints appear to be mainly high-dose effects, the type I and II
categorization does not clearly comply with the low/high-dose endpoint classification. For
example, the ED50 estimates for two type I endpoints, i.e. liver EROD activity and incisor
tooth defects, differed by more than 100-fold. However, it is likely that only some of the
effects of TCDD are primarily due to TCDD. Others may be either adaptive physiological
responses to biochemical changes, or secondary to some other toxic responses (Pohjanvirta
and Tuomisto 1994). Therefore, the diversity of the toxic effects of TCDD is problematic
in the analysis of type I and type II endpoints. For example, the biochemical and biological
processes behind the induction of EROD activity, incisor tooth defect, and liver toxicity
are diverse and involve different numbers of intermediary steps.
In the case of an endpoint that results from a chain of preceding events, it would be more
important to examine the dose-response relationships of the primary insult rather than the
final endpoint. However, this is not always possible. For example, long-term multi-step
events, such as carcinogenicity, are likely to represent an accumulation of a variety of
effects. Therefore, the long-term effects may not follow the classification criteria developed
for short-term effects (cf. Viluksela et al. 2000). Similarly, after a 20-week exposure to
TCDD, the H/W and L-E rats showed little difference in efficacy but about a 100-fold
difference in potency for plasma ASAT activity (Viluksela et al. 2000), which is a typical
type II endpoint based on short-term experiments (I, II). This implies that the primary
difference is in efficacy, and it is observed first, while toxicity or tolerance manifested after
several weeks may modify the effect, leading to secondary differences in potency.
How does endpoint categorization apply to mortality?
The studies by Pohjanvirta and co-workers (Pohjanvirta et al. 1993; Unkila et al. 1994) and
Tuomisto et al. (1999) demonstrate that, although the resistance alleles considerably affect
the potency for TCDD-induced mortality, the alleles also appear to have an effect on the
efficacy (Fig. 4). At high TCDD doses, the mortality did not increase even if the dose was
increased (low efficacy). However, the true mortality curve for H/W and line A rats is not
known because due to limited solubility of TCDD it is technically not possible to dose
these rats with higher doses than 10,000 µg/kg TCDD.  Nevertheless, the potency
differences in short-term toxicity do not seem to explain, at least alone, the differences seen
in acute lethality among the rat lines. Therefore, it can be hypothesized that mortality
belongs to type II endpoints with different efficacy in L-E and H/W rats. Lethality is
triggered only after a strong induction/activation of the underlying biological mechanism
and, due to low efficacy in H/W rats, the lethal processes are not triggered even at high
doses.
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AHR and resistance alleles in male reproduction
Role of functional AHR. It is generally believed that most, if not all of the toxic effects of
TCDD are mediated through AHR. The use of AHRKO mice has enabled the determination
of the role of AHR in TCDD toxicity, and also its possible role in the normal development.
By using these mice we showed that, in general, the effects of TCDD on growth and
functional development of the ventral, dorsolateral and anterior prostate were AHR-
dependent and were not observed in AHRKO mice (V). On the contrary, TCDD was able to
modify the development of the seminal vesicles in AHRKO mice. The biological
significance of these effects of TCDD on AHRKO mice may be questionable, but at least
they demonstrate that TCDD can also cause AHR-independent effects. The other possibility
is that mice express more than one form of AHR, as observed, for example, in zebrafish
(Andreasen et al. 2002). Consequently, not all forms of AHR might have been eliminated
from AHRKO mice. However, there is currently no evidence for the presence of more than
one form of AHR in mammals (Hahn 2002).
The AHR was also shown to be necessary for the normal development of the dorsolateral
prostate, anterior prostate, and seminal vesicle (V). The ventral prostate was most affected
by TCDD exposure in wild-type mice, but was not affected by the null mutation. In a
previous study it was shown that the development of other male reproductive organs, such
as the testis and epididymis, were affected by the AHR null mutation (Lin et al. 2001). The
role of the AHR in normal male reproductive system development is still unclear.
However, it may involve interactions of the AHR with one or more endogenous ligands, or
just be due to some unknown function of unliganded AHR.
Role of resistance alleles Ahrhw and Bhw. Despite the major role of functional AHR in
mediating the effects of TCDD on the development of accessory sex organs (V), the H/W-
type truncated AHR in line A rats was still able to mediate in a normal way the TCDD-
induced defects of the male reproductive organs after adult and perinatal TCDD exposure
(III, IV).
However, the AHR with a truncated transactivation domain appears to modify the effects of
TCDD on sperm parameters (daily sperm production and cauda epididymal sperm number)
after adult as well as in utero and lactational TCDD exposure. This may also be important
for the risk assessment of humans to dioxins as the decrease in sperm parameters is one of
the most sensitive endpoints of dioxin toxicity in rats (Roman and Peterson 1998), the
effects appear to be permanent (Mably et al. 1992c) in rats, and most of the polymorphisms
in the human AHR are located on in the transactivation domain (Harper et al. 2002). In
theory, a mutation in human AHR C-terminal end could result in decreased sensitivity to
dioxin-induced male reproductive effects as observed in rats with H/W-type mutated AHR.
However, due to the significance of this area in signal transduction, it is also possible that
other types of mutations in AHR transactivation domain could result in increased
sensitivity, although this was not observed in the present study.
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It is clear, however, that despite the minor modifying effect of the resistance alleles on the
sensitivity, the overall effects on male reproductive system observed after TCDD exposure
are to some extent influenced by the animal species and strain, as well as the dosing regime
used (Chahoud et al. 1992; Faqi et al. 1998; Gray et al. 1995; Latchoumycandane et al.
2002a; Mably et al. 1992a, b, c; McConnell et al. 1978; Moore et al. 1985; Ohsako et al.
2001; Rune et al. 1991a, b). Nevertheless, the variation in the sensitivity of species, or
strains of the same species, is in general much smaller after perinatal TCDD exposure than
in acute lethality (Gray et al. 1995; Theobald and Peterson, 1997). With respect to male
reproductive defects, no studies have been conducted with TCDD-responsive C57BL/6 and
–non-responsive DBA/2 mice to examine the influence of lower binding affinity of AHR on
sensitivity to TCDD.
5.2 The influence of developmental stage during TCDD exposure (III-VII)
The developmental stage during dioxin exposure is an important factor in dioxin toxicity, as
the most sensitive endpoints of dioxin toxicity seem to be related to developmental
processes.
5.2.1 The developing male reproductive system is more susceptible than the
adult reproductive system
The sensitivity of the growth and functional development of mouse ventral prostate during
the fetal stage is an important observation from the risk assessment point of view, as the
transfer of TCDD to offspring is highly limited during the prenatal period. The majority of
maternal TCDD body burden is transferred to pups in milk rather than across the placenta
(Abbott et al. 1989; Nau et al. 1986; Weber and Birnbaum, 1985).  This is important
because the critical period for effects of TCDD on ventral prostate development coincides
with the period of placental TCDD exposure, and not with the postnatal period of peak
TCDD transfer. In addition, the development of dorsolateral prostate, anterior prostate and
seminal vesicle are affected by in utero TCDD exposure. Therefore, it is concluded that the
development of male accessory sex organs is highly sensitive to TCDD, and adverse effects
are observed at the extremely low amounts of TCDD, which cross the placenta.
The studies on A, B and C rats also showed a clear difference in sensitivity between
developing and adult male reproductive systems, as demonstrated by the toxic effects on
prostate (III, IV). In the adult study, a single dose of 30 µg/kg TCDD in line B and C rats,
and 1000 µg/kg TCDD in line A rats, significantly decreased the weight of the ventral
prostate 17 days postexposure (IV). On the other hand, in utero and lactational exposure to
a single maternal dose of 1 µg/kg TCDD on GD15 significantly reduced the ventral prostate
weight in line A, B and C offspring, though the reduction was not permanent (III). A single
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maternal dose of 1 µg/kg TCDD on GD15 results in fetal TCDD body burden of only 36.4
ng/kg on GD21 (Hurst et al. 2000), and the rat prostate development is affected already
during the fetal period (Bjerke and Peterson 1994). Thereby, it can be concluded that the
growth of ventral prostate in these rat lines is significantly more sensitive to fetal TCDD
exposure than to adult exposure, and the sensitivity difference is at least 2-3 orders of
magnitude. This rough estimate is fairly close to the previous estimate, indicating that fetal
male reproductive defects are observed at doses approximately one hundredth of those of
adult defects (Roman and Peterson, 1998).
It is important to note that there are mechanistic differences in the way that the perinatal
and adult exposure dosing regimens decrease prostate growth and/or functional
development. An important factor associated with male reproductive organ effects after
adult TCDD exposure is the precipitous decrease in serum testosterone concentration; male
reproductive organ effects are mostly observed at doses that cause these decreases in
circulating androgen levels (IV). On the contrary, after fetal exposure to a low dose of
TCDD, there seems to be a delay in pubertal testosterone production, but as the pups get
older the levels are returned close to normal (III, V). Therefore, it seems that the primary
mechanism behind the male reproductive effects in adulthood and during development is
different.
Currently available information (Cooke et al. 1998; Faqi et al. 1998; Gray et al. 1995;
Loeffler and Peterson, 1999; Roman et al. 1995; Timms et al. 2002; III) suggests that the
in utero and lactational TCDD exposure has only a minor or no effect on androgen levels in
young adults. The mechanism may be related to the decreased androgen receptor mRNA
expression levels observed after in utero and lactational TCDD exposure in ventral prostate
gland (Ohsako et al. 2001), though this was not confirmed in the present study (V).
Recently, it was also shown with LNCaP prostate cancer cells that there could be an
interaction between AHR and androgen receptor signaling pathways (Jana et al. 1999;
Morrow et al. 2004). However, another work using an androgen receptor reporter assay
showed that TCDD did not interfere with androgen action in the urogenital sinus (Ko et al.
2004). In addition, TCDD was not shown to have antiandrogenic effect on androgen
receptor activation in Chinese hamster ovary cells transiently co-transfected with AR and
MMTV-luciferace plasmid (Vinggaard et al. 2000).
Prostate may also be a target for estrogen action (Cooke et al. 1991; Makela et al. 2000;
Nilsson et al. 2001). In fact, the prostate defects are linked to the changes in intrauterine
estradiol levels and to the sex of the neighboring fetuses inside the uterus (Timms et al.
2002). Additionally, it is also possible that the estrogenic status is changed due to
interaction between AHR and estrogen receptor signaling pathways (Kharat and Saatcioglu
1996; Ohtake et al. 2003; Safe et al. 2000; Wormke et al. 2003). However, the essential
studies to show the exact role of estrogen in TCDD-induced disturbances in prostate
development have not yet been done.
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5.2.2 Critical time windows in TCDD-induced male reproductive toxicity and
hydronephrosis.
The available data indicate that the male reproductive system is most sensitive to in utero
and lactational TCDD exposure. For determination of the vulnerable events in
organogenesis it is still important to determine the critical windows of sensitivity more
accurately within this period of life. However, a long elimination half-life of dioxins makes
the exact determination of critical windows difficult. Some organs seem to have quite
limited and clear-cut sensitive periods during their development, while others are sensitive
throughout the development (Couture et al. 1990; Miettinen et al. 2002). The present
results show that also in ventral, dorsolateral and anterior prostate as well as in seminal
vesicle development the most vulnerable stages of development differs (VI).
The initial step in prostate development is the outgrowth of epithelial buds from the
urogenital sinus into the surrounding mesenchyme (Cunha, 1972; Cunha et al. 1987). The
first buds arise at different stages of development for different prostate lobes and for
seminal vesicles. In mice the anterior prostate buds appear on GD15, followed by
dorsolateral buds on GD16 and ventral prostate buds on GD17. The seminal vesicle
rudiments develop from the caudal ends of the Wolffian ducts, and first become visible on
GD14. The working hypothesis for study VI was that the sensitivity differences between
different prostate lobes correlate with the developmental stage of bud formation during
exposure. However, the results demonstrated that there was no correlation. Ventral prostate
development was more inhibited by TCDD than was dorsolateral prostate development and
it was affected between GD13 to GD16 before the first ventral buds were visible. On the
contrary, dorsolateral prostate was most affected after GD16, when the dorsolateral buds
are already developing. The regional differences in temporal/spatial AHR expression in
rudiments of different organs or even in the urogenital sinus where the prostate lobes start
to develop might explain the different sensitivities of the lobes. However, these expression
patterns have not been studied.
A critical window for TCDD-induced hydronephrosis in C57BL/6N mice has been shown
to occur on PND1 (Couture-Haws et al. 1991). Hydronephrosis has also been reported in
H/W rat fetuses after a maternal dose of 1 or 10 µg/kg TCDD on GD8 (Huuskonen et al.
1994). Surprisingly, in the present study hydronephrosis was observed with high frequency
and severity in line A and B rats exposed to TCDD as late as the first two weeks of life.
Therefore, our data indicate that in rats, the period of sensitivity to hydronephrosis is
extended postnatally until at least 17 days of age, if the dose is high enough.
Knowledge of the critical stages in TCDD toxicity is essential in exploring the primary
toxic mechanisms of TCDD. The critical stages in prostate development enabled us to focus
on the more sensitive time-period in mechanistic studies. Studies done after the publication
of the papers on which this thesis is based have elucidated the effects of TCDD on region-
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specific urogenital sinus bud formation (Lin et al. 2003). In mice, ventral prostate epithelial
bud formation was prevented by maternal dose of 5 µg/kg TCDD on GD13. In addition, the
number of dorsolateral buds was reduced, and dorsal, lateral and anterior prostate budding
was delayed by approximately one day. This early effect of TCDD on bud formation was
mediated through AHR. To identify the molecular mechanism, by which TCDD disrupts
urogenital sinus development, the new methods termed as “-omic” technologies were
applied. The gene expression profiling was done at the RNA (transcriptomics) and protein
(proteomics) level. Affymetrix Microarrays were used to measure the region-specific gene
expression in the mouse urogenital sinus. Urogenital sinuses were collected from GD16
male fetuses after maternal dose of 5 µg/kg TCDD on GD13 (Lin et al. 2002). The genes
found differently expressed are involved in neural development, cell adhesion, growth
factor signaling pathways as well as in cytoskeletal and extracellular matrix composition. In
addition, by using the proteomics tools we have started to examine the changes in mouse
urogenital sinus proteome on GD16, after a maternal dose of 5 µg/kg TCDD on GD13
(Karjanlahti et al. 2004).
5.2.3 Development of resistance to type II endpoint.
A previous teratogenicity study demonstrated only a slight strain difference in prenatal
mortality between H/W and L-E rats. Postimplantation loss, resorptions and late fetal
deaths were almost as common in H/W rats at 10 µg/kg TCDD as in L-E rats at 5 µg/kg
(Huuskonen et al. 1994). However, we demonstrated that TCDD-resistant H/W and line A
rats were fairly resistant to TCDD already few days after birth, and the full resistance was
achieved in two weeks. These findings suggest that the prenatal sensitivity of these rat
strains may be related to maternal and/or placental factors independent of the resistance
alleles Ahrhw and Bhw that are known to be involved in the determination of resistance of
these rats postnatally. Placenta is a likely candidate, as several studies have shown that it is
a target of TCDD toxicity (Chen et al. 2002; Hassoun et al. 1995, 1997; Ishimura et al.
2002a, b; Khera 1992).
Interestingly, the time course for resistance development in line B rats differed from that of
line A and H/W rats. TCDD resistance in line B rats was attained at the age of 28 days in
females and 42 days in males. This time difference indicates that the time-course of
resistance development associated with Ahrhw and Bhw alleles is different, and reflects that
there are differences in pathways mediating resistance between these alleles.
At high TCDD doses, the growth and weight gain was only slightly affected by the age of
an offspring during the exposure, and no specific differences between Ahrhw and Bhw alleles
could be detected. Animals dosed at younger ages did not seem to reach the body weight of
the animals dosed at an older age even in 100 days, and neither line A nor line B developed
full resistance to the effects of high TCDD doses on body weight. Furthermore, in
accordance with the hypothesis of TCDD-triggered dose-dependent decrease in the putative
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set-point for body weight (Seefeld et al. 1984), the difference in body weight seen shortly
after exposure remained fairly constant as the rats aged.
5.3 Implications for dioxin risk assessment
The TEFs are essential in human risk assessment of complex environmental mixtures of
dioxins. The short-term non-lethal endpoints of toxicity (at doses of 3000 µg/kg TCDD or
less) followed the normal rank order of dioxin sensitivity, and the REP values were in
relatively good accordance with the current TEF values (I). Results of this thesis also
showed that the influence of resistance alleles is endpoint dependent. Therefore, the
measured endpoint, as well as the strain (or species) may significantly affect the REP
derived from a single study, and may therefore affect the derived TEF estimate, especially
for type II endpoints (I-IV). This study strongly supports the current use of the TEF
concept when REPs from various studies are combined, and indicate that the observed
deviations in dioxin structure-activity relationships of acute lethality are not relevant for
dioxin risk assessment.
The research on the role of genetic factors in dioxin toxicity has mainly been limited to the
dioxin-induced mortality and other high-dose effects, while their significance in the
sensitivity to low dose effects, especially to developmental defects has been less studied.
The present study demonstrated that, the resistance alleles Ahrhw and Bhw do not
significantly influence the sensitivity to TCDD-induced male reproductive organ defects
after perinatal exposure, although the effects on accessory sex organs are mediated through
AHR (III, V). However, after in utero and lactational TCDD exposure the extent of
decrease in sperm parameters was affected by the resistance alleles. In accordance with our
findings, other similarly designed studies with a variety of rat strains (and even with other
rodent species) have shown that, although the sensitivity to male reproductive defects is to
some extent strain specific and, therefore, affected by certain genetic factors, the sensitivity
differences are still very small from the risk assessment point of view. In addition, it is
apparent that the dosing protocol could have some influence on the observed adverse
effects and their sensitivity. Repeated dosing for prolonged periods would more closely
resemble the human dioxin exposure than does single dosing but for practical reasons the
single dose protocol has been widely used. Overall, in terms of risk assessment it is
important to recognize that effects do occur, and the TCDD sensitivity is only slightly
affected by resistance alleles. This makes the extrapolation from experimental animal to
human more straightforward.
In addition, data of this thesis confirm the earlier findings indicating that the developmental
processes, especially during the fetal period, are highly sensitive to TCDD toxicity (III-VI).
There is variation in critical periods of certain developmental processes and, therefore, it is
important to pay attention to the dosing procedure when assessing the presence and/or
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absence of certain defects. Additionally, the differences observed in the critical periods of
sensitivity in the development of different male accessory sex organs provide further
information on the mechanism behind the defects. The critical windows for male
reproductive effects in mouse begin around GD13 to GD16. The corresponding human
developmental stage is 5-12 weeks. At that time the maternal tissue concentrations
associated with adverse effects in experimental animals are close to the range of human
background exposure to dioxin-like compounds (Fig. 5). In general, the study emphasizes
the particular importance of the fetus but also nursing infants as primary concern in human
risk assessment.
a
 The maternal fat concentrations in rat were estimated based on Hurst et al. (2000)
b
 Delayed puberty measured at the age of approximately 40 days.
c
 Decreased ejaculated sperm number measured at the age of 15 months.
d
 Pregnant Long-Evans hooded rats were treated with single dose of 0.05-0.8 µg/kg TCDD
on GD15.
e
 Pregnant Holtzman rats were treated with single dose of 0.05-0.8 µg/kg TCDD on GD15.
Fig. 5 Comparison of lipid-based dioxin concentration in mother’s milk determined in
general population in 1993-1994 and in pregnant rat (gestation day 16) a, as well as male
reproductive defects occurring in pups born to rats exposed at the age of 63 days.
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6 Conclusions
1. The exceptional sensitivity of H/W rats to higher chlorinated dioxins is limited to acute
lethality.
2. There are two types of endpoints of short-term dioxin toxicity. Type I endpoints (EROD
activity, thymus weight, tooth defect) are independent of genotype variation while in
type II endpoints (e.g. weight loss, serum bilirubin) the efficacy is suppressed by the
resistance alleles, the Ahrhw allele being the most important factor. The efficacy ratio of
0.5 classifies the effects into type I and type II categories.
3. TCDD effects on male reproductive organs after adult or perinatal TCDD exposure are
not modified by the resistance alleles and therefore belong to type I endpoints.
However, resistance to TCDD-induced decrease in sperm parameters appears to be
increased by the resistance alleles.
4. The effects of TCDD on the growth and functional development of male accessory sex
organs in mice are mainly AHR-dependent.
5. The developing male reproductive system is more susceptible than the adult
reproductive system to the toxic effects of TCDD.
6. The critical time window of TCDD sensitivity is prostate lobe specific. Ventral and
anterior prostate growth was most affected during fetal period, while dorsolateral
prostate required both fetal and postnatal exposure for maximal effect.
7. The full resistance of H/W and line A rats to mortality develops after birth, and the
time-course for the resistance development differs between the resistance alleles Ahrhw
and Bhw.
8. The period of sensitivity to hydronephrosis is extended postnatally until at least 17 days
of age at high doses of TCDD, and the sensitivity does not differ between the resistance
alleles Ahrhw and Bhw.
9. The results strongly support the current use of TEF concept in dioxin risk assessment.
The observed deviations are not relevant for the risk assessment.
10. The study emphasizes the importance of the fetus, in particular, but also nursing infants
as primary concern in human risk assessment.
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